36th International Symposium on Intensive Care and Emergency Medicine : Brussels, Belgium. 15-18 March 2016

P001 - Sepsis impairs the capillary response within hypoxic capillaries and decreases erythrocyte oxygen-dependent ATP efflux

R. M. Bateman, M. D. Sharpe, J. E. Jagger, C. G. Ellis

P002 - Lower serum immunoglobulin G2 level does not predispose to severe flu.

J. Solé-Violán, M. López-Rodríguez, E. Herrera-Ramos, J. Ruíz-Hernández, L. Borderías, J. Horcajada, N. González-Quevedo, O. Rajas, M. Briones, F. Rodríguez de Castro, C. Rodríguez Gallego

P003 - Brain protective effects of intravenous immunoglobulin through inhibition of complement activation and apoptosis in a rat model of sepsis

F. Esen, G. Orhun, P. Ergin Ozcan, E. Senturk, C. Ugur Yilmaz, N. Orhan, N. Arican, M. Kaya, M. Kucukerden, M. Giris, U. Akcan, S. Bilgic Gazioglu, E. Tuzun

P004 - Adenosine a1 receptor dysfunction is associated with leukopenia: A possible mechanism for sepsis-induced leukopenia

R. Riff, O. Naamani, A. Douvdevani

P005 - Analysis of neutrophil by hyper spectral imaging - A preliminary report

R. Takegawa, H. Yoshida, T. Hirose, N. Yamamoto, H. Hagiya, M. Ojima, Y. Akeda, O. Tasaki, K. Tomono, T. Shimazu

P006 - Chemiluminescent intensity assessed by eaa predicts the incidence of postoperative infectious complications following gastrointestinal surgery

S. Ono, T. Kubo, S. Suda, T. Ueno, T. Ikeda

P007 - Serial change of c1 inhibitor in patients with sepsis – A prospective observational study

T. Hirose, H. Ogura, H. Takahashi, M. Ojima, J. Kang, Y. Nakamura, T. Kojima, T. Shimazu

P008 - Comparison of bacteremia and sepsis on sepsis related biomarkers

T. Ikeda, S. Suda, Y. Izutani, T. Ueno, S. Ono

P009 - The changes of procalcitonin levels in critical patients with abdominal septic shock during blood purification

T. Taniguchi, M. O

P010 - Validation of a new sensitive point of care device for rapid measurement of procalcitonin

C. Dinter, J. Lotz, B. Eilers, C. Wissmann, R. Lott

P011 - Infection biomarkers in primary care patients with acute respiratory tract infections – Comparison of procalcitonin and C-reactive protein

M. M. Meili, P. S. Schuetz

P012 - Do we need a lower procalcitonin cut off?

H. Hawa, M. Sharshir, M. Aburageila, N. Salahuddin

P013 - The predictive role of C-reactive protein and procalcitonin biomarkers in central nervous system infections with extensively drug resistant bacteria

V. Chantziara, S. Georgiou, A. Tsimogianni, P. Alexandropoulos, A. Vassi, F. Lagiou, M. Valta, G. Micha, E. Chinou, G. Michaloudis

P014 - Changes in endotoxin activity assay and procalcitonin levels after direct hemoperfusion with polymyxin-b immobilized fiber

A. Kodaira, T. Ikeda, S. Ono, T. Ueno, S. Suda, Y. Izutani, H. Imaizumi

P015 - Diagnostic usefullness of combination biomarkers on ICU admission

M. V. De la Torre-Prados, A. Garcia-De la Torre, A. Enguix-Armada, A. Puerto-Morlan, V. Perez-Valero, A. Garcia-Alcantara

P016 - Platelet function analysis utilising the PFA-100 does not predict infection, bacteraemia, sepsis or outcome in critically ill patients

N. Bolton, J. Dudziak, S. Bonney, A. Tridente, P. Nee

P017 - Extracellular histone H3 levels are inversely correlated with antithrombin levels and platelet counts and are associated with mortality in sepsis patients

G. Nicolaes, M. Wiewel, M. Schultz, K. Wildhagen, J. Horn, R. Schrijver, T. Van der Poll, C. Reutelingsperger

P018 - Il-8: is this a more reliable biomarker for sepsis severity than CRP, Procalcitonin, E-selectin, IL-6 and TNF-[alpha]

S. Pillai, G. Davies, G. Mills, R. Aubrey, K. Morris, P. Williams, P. Evans

P019 - Relation between adrenomedullin and short-term outcome in ICU patients: Results from the frog ICU study

E. G. Gayat, J. Struck, A. Cariou, N. Deye, B. Guidet, S. Jabert, J. Launay, M. Legrand, M. Léone, M. Resche-Rigon, E. Vicaut, A. Vieillard-Baron, A. Mebazaa

P020 - Impact of disease severity assessment on performance of heparin-binding protein for the prediction of septic shock

R. Arnold, M. Capan, A. Linder, P. Akesson

P021 - Kinetics and prognostic value of presepsin (sCD14) in septic patients. A pilot study

M. Popescu, D. Tomescu

P022 - Comparison of CD64 levels performed by the facs and accellix systems

C. L. Sprung, R. Calderon Morales, G. Munteanu, E. Orenbuch-Harroch, P. Levin, H. Kasdan, A. Reiter, T. Volker, Y. Himmel, Y. Cohen, J. Meissonnier

P023 - Diagnosing sepsis in 5 minutes: Nanofluidic technology study with pancreatic-stone protein (PSP/ reg)

L. Girard, F. Rebeaud

P024 - How nanotechnology-based approaches could contribute to sepsis prevention, diagnosis and treatment

I. Herrmann

P025 - Il7r transcriptional expression analysis during septic shock

B. Delwarde, E. Peronnet, E. Cerrato, F. Venet, A. Lepape, T. Rimmelé, G. Monneret, J. Textoris

P026 - Disbalance of microbial metabolites of aromatic acids affects the severity in critically ill patients

N. Beloborodova, V. Moroz, A. Osipov, A. Bedova, Y. Sarshor, A. Pautova, A. Sergeev, E. Chernevskaya

P027 - Copeptin predicts 10-year all-cause mortality in community patients

J. Odermatt, R. Bolliger, L. Hersberger, M. Ottiger, M. Christ-Crain, B. Mueller, P. Schuetz

P028 - Identification of differential proteomic response in septic patients secondary to community and hospital acquired pneumonia

N. K. Sharma, A. K. Tashima, M. K. Brunialti, F. R. Machado, M. Assuncao, O. Rigato, R. Salomao

P029 - Monocyte HLA-DR expression in community-acquired bacteremic sepsis - dynamics associated to aetiology and prediction of secondary sepsis

S. C. Cajander, G. Rasmussen, E. Tina, B. Söderquist, J. Källman, K. Strålin

P030 - Soluble B- and T-lymphocyte attenuator: A possible prognostic marker in sepsis

A. L. Lange, J. S. Sundén-Cullberg, A. M. Magnuson, O. H. Hultgren

P031 - Fractal dimension: A new biomarker for quantifying clot microstructure in patients across the sepsis spectrum

G. Davies, S. Pillai, G. Mills, R. Aubrey, K. Morris, P. Williams, P. Evans

P032 - Comparison between the new biomarker for coagulation, clot microstructure (Df) with rotational thromboelastometry (ROTEM) in patients across the sepsis spectrum

S. Pillai, G. Davies, G. Mills, R. Aubrey, K. Morris, P. Williams, P. Evans

P033 - Changes in fibrinolysis across the sepsis spectrum: The use of rotational thromboelastometry (ROTEM) lysis index (LI60) and D-Dimer concentration

S. Pillai, G. Davies, G. Mills, R. Aubrey, K. Morris, P. Williams, P. Evans

P034 - The intensive care infection score – a promising marker for the prediction of infection and its severity.

P. Van der Geest, M. Mohseni, J. Linssen, R. De Jonge, S. Duran, J. Groeneveld

P035 - Challenges in the clinical diagnosis of sepsis

R. Miller III, B. K. Lopansri, L. C. McHugh, A. Seldon, J. P. Burke

P036 - Does zero heat flux thermometry more accurately identify sepsis on intensive care?

J. Johnston, R. Reece-Anthony, A. Bond, A. Molokhia

P037 - Advancing quality (AQ) sepsis programme: Improving early identification & treatment of sepsis in North West England.

C. Mcgrath, E. Nsutebu

P038 - Prehospital transport of acute septic patients

P. Bank Pedersen, D. Pilsgaard Henriksen, S. Mikkelsen, A. Touborg Lassen

P039 - Vasodilatory plant extracts gel as an alternative treatment for fever in critically ill patients

R. Tincu, C. Cobilinschi, D. Tomescu, Z. Ghiorghiu, R. Macovei

P040 - Host response and outcome of hypothermic sepsis

M. A. Wiewel, M. B. Harmon, L. A. Van Vught, B. P. Scicluna, A. J. Hoogendijk, J. Horn, A. H. Zwinderman, O. L. Cremer, M. J. Bonten, M. J. Schultz, T. Van der Poll, N. P. Juffermans, W. J. Wiersinga

P041 - Septic shock alert over SIRS criteria has an impact on outcome but needs to be revised

G. Eren, Y Tekdos, M. Dogan, O. Acicbe, E. Kaya, O. Hergunsel

P042 - Association between previous prescription of βblockers and mortality rate among septic patients: A retrospective observational study

S. Alsolamy, G. Ghamdi, L. Alswaidan, S. Alharbi, F. Alenezi, Y. Arabi

P043 - Recognition and treatment of sepsis on labour ward– teaching & information resources can improve knowledge

J. Heaton, A. Boyce, L. Nolan, J. Johnston, A. Dukoff-Gordon, A. Dean, A. Molokhia

P044 - Culture negative sepsis in the ICU – what is unique to this patient population?

T. Mann Ben Yehudah

P045 - Organ dysfunction in severe sepsis patients identified in administrative data in Germany, 2007-2013

C. Fleischmann, D. Thomas-Rueddel, C. Haas, U. Dennler, K. Reinhart

P046 - A comparison of residents’ knowledge regarding; the Surviving Sepsis Campaign 2012 guideline

O. Suntornlohanakul, B. Khwannimit

P047 - Effectiveness of a septic shock bundle to improve outcomes in the ICU

F. Breckenridge, A. Puxty

P048 - Dose of norepinephrine in the first 24 hours as a parameter evaluating the effectiveness of treatment in patients with severe sepsis and septic shock

P. Szturz, P. Folwarzcny, J. Svancara, R. Kula, P. Sevcik

P049 - Norepinephrine or vasopressin + norepinephrine in septic shock. A retrospective series of 39 patients

L. Caneva, A. Casazza, E. Bellazzi, S. Marra, L. Pagani, M. Vetere, R. Vanzino, D. Ciprandi, R. Preda, R. Boschi, L. Carnevale

P050 - Methylene blue effectiveness as contributory treatment in patients with septic shock

V. Lopez, M. Aguilar Arzapalo, L. Barradas, A. Escalante, J. Gongora, M. Cetina

P051 - Coagulation disorders in patients with severe sepsis and DIC evaluated with thromboelastometry.

B Adamik, D Jakubczyk, A Kübler

P052 - Frequency and outcome of early sepsis-associated coagulopathy

A. Radford, T. Lee, J. Singer, J. Boyd, D. Fineberg, M. Williams, J. Russell

P053 - Assessment of coagulopathy in cancer patients with severe sepsis or septic shock. A case-control pilot study

E. Scarlatescu, D. Tomescu, G. Droc, S. Arama

P054 - Thromboelastometry in critically ill patients with disseminated intravascular coagulation

M. Müller, M. Straat, S. S. Zeerleder, N. P. Juffermans

P055 - Cessation of a preexisting chronic antiplatelet therapy is associated with increased mortality rates in severe sepsis and septic shock

C. F. Fuchs, C. S. Scheer, S. W. Wauschkuhn, M. V. Vollmer, K. M. Meissner, S. K. Kuhn, K. H. Hahnenkamp, S. R. Rehberg, M. G. Gründling

P056 - Neutrophil Extracellular Traps (NETs) production under hypoxic condition

N. Yamamoto, M. Ojima, S. Hamaguchi, T. Hirose, Y. Akeda, R. Takegawa, O. Tasaki, T. Shimazu, K. Tomono

P057 - Impact of ultraviolet air sterilizer in intensive care unit room, and clinical outcomes of patients

E. Gómez-Sánchez, M. Heredia-Rodríguez, E. Álvarez-Fuente, M. Lorenzo-López, E. Gómez-Pesquera, M. Aragón-Camino, P. Liu-Zhu, A. Sánchez-López, A. Hernández-Lozano, M. T. Peláez-Jareño, E. Tamayo

P058 - Focus of infection in severe sepsis - comparison of administrative data and prospective cohorts from Germany

D. O. Thomas-Rüddel, C. Fleischmann, C. Haas, U. Dennler, K. Reinhart

P059 - “Zero CLABSI” – can we get there? Obstacles on the 4 year journey and our strategies to overcome them – experience from an Indian ICU

V. Adora, A. Kar, A. Chakraborty, S. Roy, A. Bandyopadhyay, M. Das

P060 - Novel molecular techniques to identify central venous catheter (CVC) associated blood stream infections (BSIs)

T. Mann Ben Yehudah, G. Ben Yehudah, M. Salim, N. Kumar, L. Arabi, T. Burger, P. Lephart, E. Toth-martin

P061 - Zero clabsi” – can we get there? Obstacles on the 4 year journey and our strategies to overcome them – experience from an Indian ICU

R. Rao, A. Kar, A. Chakraborty

P062 - Prevention of central line-associated bloodstream infections in intensive care units: An international online survey

C. Valencia, N. Hammami, S. Blot, J. L. Vincent, M. L. Lambert

P063 - 30 days antimicrobial efficacy of non-leaching central venous catheters

J. Brunke, T. Riemann, I. Roschke

P064 - Efficacy of noble metal alloy-coated catheter in prevention of bacteriuria

R. Tincu, C. Cobilinschi, D. Tomescu, Z. Ghiorghiu, R. Macovei

P065 - Predicting bacteremic urinary tract infection in community setting: A prospective observational study

S. Nimitvilai, K. Jintanapramote, S. Jarupongprapa

P066 - Eight-year analysis of acinetobacter spp. monobacteremia in surgical and medical intensive care units at university hospital in Lithuania

D. Adukauskiene, D. Valanciene

P067 - Group A and group B streptococcal infections in intensive care unit – our experience in a tertiary centre

G. Bose, V. Lostarakos, B. Carr

P068 - Improved detection of spontaneous bacterial peritonitis by uritop + tm strip test and inoculation of blood culture bottles with ascitic fluid

S. Khedher, A. Maaoui, A. Ezzamouri, M. Salem

P069 - Increased risk of cellulitis in patients with congestive heart failure: a population based cohort study

J. Chen

P070 - Outcomes of severe cellulitis and necrotizing fasciitis in the critically ill

D. R. Cranendonk, L. A. Van Vught, M. A. Wiewel, O. L. Cremer, J. Horn, M. J. Bonten, M. J. Schultz, T. Van der Poll, W. J. Wiersinga

P071 - Botulism outbreak associated with people who inject drugs (PWIDs) in Scotland.

M. Day, G. Penrice, K. Roy, P. Robertson, G. Godbole, B. Jones, M. Booth, L. Donaldson

P072 - Surveillance of ESBL-producing enterobacteriaceae fecal carriers in the ICU

Y. Kawano, H. Ishikura

P073 - Prevalence of ESBL and carbapenemase producing uropathogens in a newly opened hospital in south India

S. Sreevidya, N. Brahmananda Reddy, P. Muraray Govind, R. Pratheema, J. Devachandran

Apollo Speciality Hospital - OMR, Chennai, India

P074 - Prevalence, risk factors and outcomes of methicillin-resistant staphylococcus aureus nasal colonization in critically ill patients

H. Al-Dorzi, M. Almutairi, B. Alhamadi, A. Crizaldo Toledo, R. Khan, B. Al Raiy, Y. Arabi

P075 - Multidrug-resistant Acinetobacter baumannii infection in intensive care unit patients in a hospital with building construction: Is there an association?

H. Talaie

P076 - Multidrug-resistant organisms in a Dutch ICU

J. A. Van Oers, A. Harts, E. Nieuwkoop, P. Vos

P077 - Epidemiology and risk factors of ICU acquired infections caused by multidrug-resistant gram negative bacilli

Y. Boussarsar, F. Boutouta, S. Kamoun, I. Mezghani, S. Koubaji, A. Ben Souissi, A. Riahi, M. S. Mebazaa

P078 - Improving outcomes of severe infections by multidrug-resistant pathogens with polyclonal IgM-enriched immunoglobulins

E. Giamarellos-Bourboulis, N. Tziolos, C. Routsi, C. Katsenos, I. Tsangaris, I. Pneumatikos, G. Vlachogiannis, V. Theodorou, A. Prekates, E. Antypa, V. Koulouras, N. Kapravelos, C. Gogos, E. Antoniadou, K. Mandragos, A. Armaganidis

P079 - Must change the medical practice in ICU?

A. R. Robles Caballero, B. Civantos, J. C. Figueira, J. López

P080 - Mediterranean spotted fever in an infectious diseases intensive care unit

A. Silva-Pinto, F. Ceia, A. Sarmento, L. Santos

P081 - Clinical features and outcomes of patients with Middle East respiratory syndrome requiring admission to a saudi intensive care unit: A retrospective analysis of 31 cases

G. Almekhlafi, Y. Sakr

P082 - The ICU response to a hospital outbreak of Middle East respiratory syndrome coronavirus infection

H. Al-Dorzi, R. Khan, S. Baharoon, A. Aldawood, A. Matroud, J. Alchin, S. Al Johani, H. Balkhy, Y. Arabi

P083 - Middle East respiratory syndrome: Surveillance data analysis

S. Alsolamy, S. Y. Yousif, B. O. Alotabi, A. S. Alsaawi

P085 - Use of Taqman array card molecular diagnostics in severe pneumonia: A case series

J. Ang, MD Curran, D. Enoch, V. Navapurkar, A. Conway Morris

P086 - ‘BUNS’: An investigation protocol improves the ICU management of pneumonia

R. Sharvill, J. Astin

P087 - Pneumonia in patients following secondary peritonitis: epidemiological features and impact on mortality

M. Heredia-Rodríguez, E. Gómez-Sánchez, M. T. Peláez-Jareño, E. Gómez-Pesquera, M. Lorenzo-López, P. Liu-Zhu, M. Aragón-Camino, A. Hernández-Lozano, A. Sánchez-López, E. Álvarez-Fuente, E. Tamayo

P088 - The use of the “CURB-65 score” by emergency room clinicians in a large teaching hospital

J. Patel, C. Kruger

P089 - Incidence of community acquired pneumonia with viral infection in mechanically ventilated patients in the medical intensive care unit

J. O’Neal, H. Rhodes, J. Jancik

P090 - The SAATELLITE Study: Prevention of S aureus Nosocomial Pneumonia (NP) with MEDI4893, a Human Monoclonal Antibody (mAb) Against S aureus

B. François, P. F. Laterre, P. Eggimann, A. Torres, M. Sánchez, P. F. Dequin, G. L. Bassi, J. Chastre, H. S. Jafri

P091 - Risk factors and microbiological profile for nosocomial infections in trauma patients

M. Ben Romdhane, Z. Douira, S. Kamoun, M. Bousselmi, A. Ben Souissi, Y. Boussarsar, A. Riahi, M.S. Mebazaa

P092 - Correlation between percentages of ventilated patients developed vap and use of antimicrobial agents in ICU patients.

A. Vakalos, V. Avramidis

P093 - A comparison of two ventilator associated pneumonia surveillance techniques

T. H. Craven, G. Wojcik, K. Kefala, J. McCoubrey, J. Reilly, R. Paterson, D. Inverarity, I. Laurenson, T. S. Walsh

P094 - Lung ultrasound before and after fiberbronchoscopy - modifications may improve ventilator-associated pneumonia diagnosis

S. Mongodi, B. Bouhemad, A. Orlando, A. Stella, G. Via, G. Iotti, A. Braschi, F. Mojoli

P095 - Comparing the accuracy of predictors of mortality in ventilator-associated pneumonia

M. Haliloglu, B. Bilgili, U. Kasapoglu, I. Sayan, M. Süzer Aslan, A. Yalcın, I. Cinel

P096 - Impact of pRBCs transfusion on percentage of ventilated patients developed VAP in ICU patients

A. Vakalos, V. Avramidis

P097 - The impact of a series of interventions on the rate of ventilator associated pneumonia in a large teaching hospital

H. E. Ellis, K. Bauchmuller, D. Miller, A Temple

P098 - The EVADE study: Prevention of Nosocomial Pneumonia (NP) caused by P aeruginosa with MEDI3902, a Novel Bispecific Monoclonal Antibody, against P aeruginosa virulence factors

J. Chastre, B. François, A. Torres, C. E. Luyt, M. Sánchez, M. Singer, H. S. Jafri

P099 - Short-term inhaled colistin adjunctive therapy for ventilator-associated pneumonia

Y. Nassar, M. S. Ayad

P100 - Effect of aerosolised colistin on weaning from mechanical ventilation

A. Trifi, S. Abdellatif, F. Daly, R. Nasri, S. Ben Lakhal

P101 - Septic shock is an independent risk factor for colistin-induced severe acute kidney injury: a retrospective cohort study

B. Bilgili, M. Haliloglu, F. Gul, I. Cinel

P102 - Nosocomial pneumonia - emphasis on inhaled tobramycin

A. Kuzovlev, A. Shabanov, S. Polovnikov, V. Moroz

P103 - In vitro evaluation of amikacin inhale and commercial nebulizers in a mechanical ventilator

N. Kadrichu, T. Dang, K. Corkery, P. Challoner

P104 - The effects of nebulized amikacin/fosfomycin and systemic meropenem on severe amikacin-resistant meropenem-susceptible P.aeruginosa pneumonia

G. Li Bassi, E. Aguilera, C. Chiurazzi, C. Travierso, A. Motos, L. Fernandez, R. Amaro, T. Senussi, F. Idone, J. Bobi, M. Rigol, A. Torres

P105 - Optimization of gentamicin peak concentrations in critically ill patients

C. J. Hodiamont, N. P. Juffermans, J. M. Janssen, C. S. Bouman, R. A. Mathôt, M. D. De Jong, R. M. Van Hest

P106 - Systematic review of cefepime induced neurotoxicity

L. Payne, G. L. Fraser

P107 - Unasyn® causes QT prolongation during treatment of intensive care patients

B. Tudor, M. Lahner, G. Roth, C. Krenn

P108 - Comparative study between teicoplanin and vancomycin in methicillin-resistant staphylococcus aureus (mrsa) infectious of toxicological intensive care unit (ticu) patients – Tehran, Iran

H. Talaie

P109 - Phage therapy against antimicrobial resistance, design of the first clinical study phagoburn

P. Jault, J. Gabard, T. Leclerc, S. Jennes, Y. Que, A. Rousseau, F. Ravat

P110 - Antibiotic dosing errors in critically ill patients with severe sepsis or septic shock

H. Al-Dorzi, A. Eissa, S. Al-Harbi, T. Aldabbagh, R. Khan, Y. Arabi

P111 - Does empiric antifungal therapy improve survival in septic critically ill patients? (immunocompromised excluded)

A. Trifi, S. Abdellatif, F. Daly, R. Nasri, S. Ben Lakhal

P112 - Neurocysticercosis-Qatar experience

F. Paramba, N. Purayil, V. Naushad, O. Mohammad, V. Negi, P. Chandra

P113 - Early indicators in acute haemorrhagic shock

A. Kleinsasser

P114 - Filtering of red blood cells reduces the inflammatory response of pulmonary cells in an in vitro model of mechanical ventilation

M. R. Witrz, J. F. Buchner-Doeven, A. M. Tuip-de Boer, J. C. Goslings, N. P. Juffermans

P115 - Microparticles from red blood cell transfusion induce a pro-coagulant and pro-inflammatory endothelial cell response

M. Van Hezel, M. Straat, A Boing, R Van Bruggen, N Juffermans

P116 - The contribution of cytokines on thrombosis development during hospitalization in ICU

D. Markopoulou, K. Venetsanou, V. Kaldis, D. Koutete, D. Chroni, I. Alamanos

P117 - Prophylactic enoxaparin dosing and adjustment through anti-xa monitoring in an inpatient burn unit

L. Koch, J. Jancik, H. Rhodes, E. Walter

P118 - Determination of optimal cut-off values of haemoglobin, platelet count and fibrinogen at 24 hours after injury associated with mortality in trauma patients

K. Maekawa, M. Hayakawa, S. Kushimoto, A. Shiraishi, H. Kato, J. Sasaki, H. Ogura, T. Matauoka, T. Uejima, N. Morimura, H. Ishikura, A. Hagiwara, M. Takeda

P119 - Trauma-induced coagulopathy - prothrombin complex concentrate vs fresh frozen plasma

O. Tarabrin, S. Shcherbakow, D. Gavrychenko, G. Mazurenko, V. Ivanova, O. Chystikov

P120 - First study to prove the superiority of prothrombin complex concentrates on mortality rate over fresh frozen plasma in patients with acute bleeding

C. Plourde, J. Lessard, J. Chauny, R. Daoust

P121 - Prothrombin complex concentrate vs fresh frozen plasma in obstetric massive bleeding

S. Shcherbakow, O. Tarabrin, D. Gavrychenko, G. Mazurenko, O. Chystikov

P122 - Impact of FFP transfusion on VAP in ICU patients

A. Vakalos, V. Avramidis

P123 - Preoperative platelet function test and the thrombin generation assay are predictive for blood loss after cardiac surgery

L. Kropman, L. In het Panhuis, J. Konings, D. Huskens, E. Schurgers, M. Roest, B. De Laat, M. Lance

P124 - Rotational thromboelastometry versus standard coagulation tests before surgical interventions

M. Durila, P. Lukas, M. Astraverkhava, J. Jonas

P125 - Correction of impaired clot quality and stability by fibrinogen and activated prothrombin complex concentrate in a model of severe thrombocytopenia

I. Budnik, B. Shenkman

P126 - Assessment of point-of-care prothrombin time analyzer as a monitor after cardiopulmonary bypass

H. Hayami, Y. Koide, T. Goto

P127 - Disseminated intravascular coagulation (dic) is underdiagnosed in critically ill patients: do we need d-dimer measurements?

R. Iqbal, Y. Alhamdi, N. Venugopal, S. Abrams, C. Downey, C. H. Toh, I. D. Welters

P128 - Validity of the age-adjusted d-dimer cutoff in patients with COPD

B. Bombay, J. M. Chauny, R. D. Daoust, J. L. Lessard, M. M. Marquis, J. P. Paquet

P129 - A scoping review of strategies for prevention and management of bleeding following paediatric cardiopulmonary bypass surgery

K. Siemens, D. Sangaran, B. J. Hunt, A. Durward, A. Nyman, I. A. Murdoch, S. M. Tibby

P130 - Nadir hemoglobulin during cardiopulmonary bypass: impact on postoperative morbidity and mortality

F. Ampatzidou, D. Moisidou, E. Dalampini, M. Nastou, E. Vasilarou, V. Kalaizi, H. Chatzikostenoglou, G. Drossos

P131 - Red blood cell transfusion do not influence the prognostic value of RDW in critically ill patients

S. Spadaro, A. Fogagnolo, T. Fiore, A. Schiavi, V. Fontana, F. Taccone, C. Volta

P132 - Reasons for admission in the paediatric intensive care unit and the need for blood and blood products transfusions

E. Chochliourou, E. Volakli, A. Violaki, E. Samkinidou, G. Evlavis, V. Panagiotidou, M. Sdougka

P133 - The implementation of a massive haemorrhage protocol (mhp) for the management of major trauma: a ten year, single-centre study

R. Mothukuri, C. Battle, K. Guy, G. Mills, P. Evans

P134 - An integrated major haemorrhage protocol for pre-hospital and retrieval medical teams

J. Wijesuriya, S. Keogh

P135 - The impact of transfusion thresholds on mortality and cardiovascular events in patients with cardiovascular disease (non-cardiac surgery): a systematic review and meta-analysis

A. Docherty, R. O’Donnell, S. Brunskill, M. Trivella, C. Doree, L. Holst, M. Parker, M. Gregersen, J. Almeida, T. Walsh, S. Stanworth

P136 - The relationship between poor pre-operative immune status and outcome from cardiac surgery is specific to the peri-operative antigenic threat

S. Moravcova, J. Mansell, A. Rogers, R. A. Smith, C. Hamilton-Davies

P137 - Impact of simple clinical practice guidelines for reducing post-operative atrial fibrillation after cardiac surgery.

A. Omar, M. Allam, O. Bilala, A. Kindawi, H. Ewila

P138 - Dexamethasone administration during cardiopulmonary bypass has no beneficial effects on elective postoperative cardiac surgery patients

F. Ampatzidou, D. Moisidou, M. Nastou, E. Dalampini, A. Malamas, E. Vasilarou, G. Drossos

P139 - Intra-aortic balloon counterpulsation in patients undergoing cardiac surgery (IABCS): preliminary results

G. Ferreira, J. Caldas, J. Fukushima, E. A. Osawa, E. Arita, L. Camara, S. Zeferino, J. Jardim, F. Gaioto, L. Dallan, F. B. Jatene, R. Kalil Filho, .F Galas, L. A. Hajjar

P140 - Effects of low-dose atrial natriuretic peptide infusion on cardiac surgery-associated acute kidney injury

C. Mitaka, T. Ohnuma, T. Murayama, F. Kunimoto, M. Nagashima, T. Takei, M. Tomita

P141 - Acute kidney injury influence on high sensitive troponin measurements after cardiac surgery

A. Omar, K. Mahmoud, S. Hanoura, S. Sudarsanan, P. Sivadasan, H. Othamn, Y. Shouman, R. Singh, A. Al Khulaifi

P142 - Complex evaluation of endothelial dysfunction markers for prognosis of outcomes in patients undergoing cardiac surgery

I. Mandel, S. Mikheev, I. Suhodolo, V. Kiselev, Y. Svirko, Y. Podoksenov

P143 - New-onset atrial fibrillation in intensive care: incidence, management and outcome

S. A. Jenkins, R. Griffin

P144 - One single spot measurement of the sublingual microcirculation during acute pulmonary hypertension in a pig model of shock

M. S. Tovar Doncel, A. Lima, C. Aldecoa, C. Ince

P145 - Assessment of levosimendan as a therapeutic option to recruit the microcirculation in cardiogenic shock – initial experience in cardiac ICU

A. Taha, A. Shafie, M. Mostafa, N. Syed, H. Hon

P146 - Terlipressin vs. norepinephrine in the Potential Multiorgan Donor(PMD)

F. Righetti, E. Colombaroli, G. Castellano

P147 - Echocardiography in the potential heart donor exposed to substitution hormonotherapy

F. Righetti, E. Colombaroli

P148 - Machine learning can reduce rate of monitor alarms

M. Hravnak, L. C. Chen, A. D. Dubrawski, G. C. Clermont, M. R. Pinsky

P149 - Peripherally inserted central catheters placed in the ICU

S. Gonzalez, D. Macias, J. Acosta, P. Jimenez, A. Loza, A. Lesmes, F. Lucena, C. Leon

P150 - Recordings of abnormal central venous pressure waveform morphology during an episode of pulmonary hypertension in a porcine shock model

M. S. Tovar Doncel, C. Ince, C. Aldecoa, A. Lima

P151 - Ultrasound guided central venous access technique among French intensivists

M. Bastide, J. Richecoeur, E. Frenoy, C. Lemaire, B. Sauneuf, F. Tamion, S. Nseir, D. Du Cheyron, H. Dupont, J. Maizel

P152 - Predictive ability of the Pv-aCO2 gap in patients with shock

M. Shaban, R. Kolko, N. Salahuddin, M. Sharshir, M. AbuRageila, A. AlHussain

P153 - Comparison of echocardiography and pulmonary artery catheter measurements of hemodynamic parameters in critical ill patients

P. Mercado, J. Maizel, L. Kontar, D. Titeca, F. Brazier, A. Riviere, M. Joris, T. Soupison, B. De Cagny, M. Slama

P154 - The volume clamp method for noninvasive cardiac output measurement in postoperative cardiothoracic surgery patients: a comparison with intermittent pulmonary artery thermodilution

J. Wagner, A. Körner, M. Kubik, S. Kluge, D. Reuter, B. Saugel

P155 - Hemodynamic monitoring in patients with septic shock (SS) – CPCCO (continuous pulse contour cardiac output) vs. TEE (transesophageal echocardiography)

E. Colombaroli, F. Righetti, G. Castellano

P156 - Cardiac output measurement with transthoracic echocardiography in critically ill patients: a pragmatic clinical study

T. Tran, D. De Bels, A. Cudia, M. Strachinaru, P. Ghottignies, J. Devriendt, C. Pierrakos

P157 - Left ventricular outflow tract velocity time integral correlates with stroke volume index in mechanically ventilated patients

Ó. Martínez González, R. Blancas, J. Luján, D. Ballesteros, C. Martínez Díaz, A. Núñez, C. Martín Parra, B. López Matamala, M. Alonso Fernández, M. Chana

P158 - Transpulmonary thermodilution (TPTD) derived from femoral vs. jugular central venous catheter: validation of a previously published correction formula and a proprietary correction formula for global end-diastolic volume index (GEDVI)

W. Huber, M. Eckmann, F. Elkmann, A. Gruber, I. Klein, R. M. Schmid, T. Lahmer

P160 - Dynamic arterial elastance calculated with lidcoplus monitor does not predict changes in arterial pressure after a fluid challenge in postsurgical patients

D. Bastoni, H. Aya, L. Toscani, L. Pigozzi, A. Rhodes, M. Cecconi

P159 - Venous return driving pressure and resistance in acute blood volume changes

P. W. Moller, S. Sondergaard, S. M. Jakob, J. Takala, D. Berger

P160 - Dynamic arterial elastance calculated with lidcoplus monitor does not predict changes in arterial pressure after a fluid challenge in postsurgical patients

D. Bastoni, H. Aya, L. Toscani, L. Pigozzi, A. Rhodes, M. Cecconi

P161 - Analysis of duration of post-operative goal-directed therapy protocol

C. Ostrowska, H. Aya, A. Abbas, J. Mellinghoff, C. Ryan, D. Dawson, A. Rhodes, M. Cecconi

P162 - Hemodynamic optimization – back to square one?

M. Cronhjort, O. Wall, E. Nyberg, R. Zeng, C. Svensen, J. Mårtensson, E. Joelsson-Alm

P163 - Effectiveness of fluid thoracic content measurement by bioimpedance guiding intravascular volume optimization in patients with septic shock

M. Aguilar Arzapalo, L. Barradas, V. Lopez, M. Cetina

P164 - A systematic review on the role of internal jugular vein ultrasound measurements in assessment of volume status in critical shock patients

N. Parenti, C. Palazzi, L. A. Amidei, F. B. Borrelli, S. C. Campanale, F. T. Tagliazucchi, G. S. Sedoni, D. L. Lucchesi, E. C. Carella, A. L Luciani

P165 - Importance of recognizing dehydration in medical Intensive Care Unit

M. Mackovic, N. Maric, M. Bakula

P166 - Effect of volume for a fluid challenge in septic patients

H. Aya, A. Rhodes, R. M. Grounds, N. Fletcher, M. Cecconi

P167 - Fluid bolus practices in a large Australian intensive care unit

B. Avard, P. Zhang

P168 - Liberal late fluid management is associated with longer ventilation duration and worst outcome in severe trauma patients: a retrospective cohort of 294 patients

M. Mezidi, J. Charbit, M. Ould-Chikh, P. Deras, C. Maury, O. Martinez, X. Capdevila

P169 - Association of fluids and outcomes in emergency department patients hospitalized with community-acquired pneumonia

P. Hou, W. Z. Linde-Zwirble, I. D. Douglas, N. S. Shapiro

P170 - Association of positive fluid balance with poor outcome in medicosurgical ICU patients

A. Ben Souissi, I. Mezghani, Y. Ben Aicha, S. Kamoun, B. Laribi, B. Jeribi, A. Riahi, M. S. Mebazaa

P171 - Impact of fluid balance to organ dysfunction in critically ill patients

C. Pereira, R. Marinho, R. Antunes, A. Marinho

P172 - Volume bolus in ICU patients: do we need to balance our crystalloids?

M. Crivits, M. Raes, J. Decruyenaere, E. Hoste

P173 - The use of 6 % HES solution do not reduce total fluid requirement in the therapy of patients with burn shock

V. Bagin, V. Rudnov, A. Savitsky, M. Astafyeva, I. Korobko, V. Vein

P174 - Electron microscopic assessment of acute kidney injury in septic sheep resuscitated with crystalloids or different colloids

T. Kampmeier , P. Arnemann, M. Hessler, A. Wald, K. Bockbreder, A. Morelli, H. Van Aken, S. Rehberg, C. Ertmer

P175 - Alterations of conjunctival microcirculation in a sheep model of haemorrhagic shock and resuscitation with 0.9 % saline or balanced tetrastarch

P. Arnemann, M. Hessler, T. Kampmeier, S. Rehberg, H. Van Aken, C. Ince, C. Ertmer

P176 - A single centre nested pilot study investigating the effect of using 0.9 % saline or Plasma-Lyte 148 ® as crystalloid fluid therapy on gastrointestinal feeding intolerance in mechanically ventilated patients receiving nasogastric enteral nutrition

S. Reddy, M. Bailey, R. Beasley, R. Bellomo, D. Mackle, A. Psirides, P. Young

P177 - A single centre nested pilot study investigating the effect on post-operative bleeding of using 0.9 % saline or Plasma-Lyte® 148 as crystalloid fluid therapy in adults in ICU after heart surgery

S. Reddy, M. Bailey, R. Beasley, R. Bellomo, D. Mackle, P. Young

P178 - Extreme hypernatremia and sepsis in a patient with Huntington’s dementia: a conundrum in fluid management

H. Venkatesh, S. Ramachandran, A. Basu, H. Nair

P179 - Diagnosis and management of severe hypernatraemia in the critical care setting

S. Egan, J. Bates

P180 - Correlation between arterial blood gas and electrolyte disturbances during hospitalization and outcome in critically ill patients

S. Oliveira, N. R. Rangel Neto, F. Q. Reis

P181 - Missing the “I” in MUDPILES – a rare cause of high anion gap metabolic acidosis (HAGMA)

C. P. Lee, X. L. Lin, C. Choong , K. M. Eu, W. Y. Sim , K. S. Tee, J. Pau , J. Abisheganaden

P182 - Plasma NGAL and urinary output: potential parameters for early initiation of renal replacement therapy

K. Maas, H. De Geus

P183 - Renal replacement therapy for critically ill patients: an intermittent continuity

E. Lafuente, R. Marinho, J. Moura, R. Antunes, A. Marinho

P184 - A survey of practices related to renal replacement therapy in critically ill patients in the north of England.

T. E. Doris, D. Monkhouse, T. Shipley, S. Kardasz, I Gonzalez

P185 - High initiation creatinine associated with lower 28-day mortality in critically ill patients necessitating continuous renal replacement therapy

S. Stads, A. J. Groeneveld

P186 - The impact of Karnofsky performance scale on outcomes in acute kidney injury patients receiving renal replacement therapy on the intensive care unit

I. Elsayed, N. Ward, A. Tridente, A. Raithatha

P187 - Severe hypophosphatemia during citrate-anticoagulated CRRT

A. Steuber, C. Pelletier, S. Schroeder, E. Michael, T. Slowinski, D. Kindgen-Milles

P188 - Citrate regional anticoagulation for post dilution continuous renal replacement therapy

S. Ghabina

P189 - Citrate 18 mmol/l improves anticoagulation during RRT with adsorbing filters

F. Turani, A. Belli, S. Busatti, G. Barettin, F. Candidi, F. Gargano, R. Barchetta, M. Falco

P190 - Calcium gluconate instead of calcium chloride in citrate-anticoagulated CVVHD

O. Demirkiran, M. Kosuk, S. Bozbay

P191 - Enhanced clearance of interleukin-6 with continuous veno-venous haemodialysis (CVVHD) using Ultraflux EMiC2 vs. Ultraflux AV1000S

V. Weber, J. Hartmann, S. Harm, I. Linsberger, T. Eichhorn, G. Valicek, G. Miestinger, C. Hoermann

P192 - Removal of bilirubin with a new adsorbent system: in vitro kinetics

S. Faenza, D. Ricci, E. Mancini, C. Gemelli, A. Cuoghi, S. Magnani, M. Atti

P193 - Case series of patients with severe sepsis and septic shock treated with a new extracorporeal sorbent

T. Laddomada, A. Doronzio, B. Balicco

P194 - In vitro adsorption of a broad spectrum of inflammatory mediators with CytoSorb® hemoadsorbent polymer beads

M. C. Gruda, P. O’Sullivan, V. P. Dan, T. Guliashvili, A. Scheirer, T. D. Golobish, V. J. Capponi, P. P. Chan

P195 - Observations in early vs. late use of cytosorb therapy in critically ill patients

K. Kogelmann, M. Drüner, D. Jarczak

P196 - Oxiris membrane decreases endotoxin during rrt in septic patients with basal EAA > 0,6

F. Turani, A. B. Belli, S. M. Martni, V. C. Cotticelli, F. Mounajergi, R. Barchetta

P197 - An observational prospective study on the onset of augmented renal clearance: the first report

S. Morimoto, H. Ishikura

P198 - An ultrasound- guided algorithm for the management of oliguria in severe sepsis

I. Hussain, N. Salahuddin, A. Nadeem, K. Ghorab, K. Maghrabi

P199 - Ultrasound in acute kidney injury (aki). First findings of farius, an education-programme in structural ultrasonography

S. K. Kloesel, C. Goldfuss, A. Stieglitz, A. S. Stieglitz, L. Krstevska, G. Albuszies

P200 - Effectiveness of renal angina index score predicting acute kidney injury on critically ill patients

M. Aguilar Arzapalo, L. Barradas, V. Lopez, A. Escalante, G. Jimmy, M. Cetina

P201 - Time length below blood pressure thresholds and progression of acute kidney injury in critically ill patients with or without sepsis: a retrospective, exploratory cohort study

J. Izawa, T. Iwami, S. Uchino, M. Takinami, T. Kitamura, T. Kawamura

P202 - Anaemia does not affect renal recovery in acute kidney injury

J. G. Powell-Tuck, S. Crichton, M. Raimundo, L. Camporota, D. Wyncoll, M. Ostermann

P203 - Estimated glomerular filtration rate based on serum creatinine: actual practice in Dutch ICU’s

A. Hana, H. R. De Geus

P204 - Comparison of estimated glomerular filtration rate calculated by mdrd, ckd-epi-serum-creatinine and ckd-epi-cystatin-c in adult critically ill patients

H. R. De Geus, A. Hana

P205 - Early diagnosis of septic acute kidney injury in medical critical care patients with a urine cell cycle arrest marker: insulin like growth factor binding protein-7 (IGFBP-7)

M. Aydogdu, N. Boyaci, S. Yuksel, G. Gursel, A. B. Cayci Sivri

P206 - Urinary neutrophil gelatinase-associated lipocalin as early biomarker of severe acute kidney injury in intensive care

J. Meza-Márquez, J. Nava-López, R. Carrillo-Esper

P207 - Shrunken pore syndrome is associated with a sharp rise in mortality in patients undergoing elective coronary artery bypass grafting

A. Dardashti, A. Grubb

P208 - The biomarker nephrocheck™ can discriminate the septic shock patients with an akin 1 or 2 acute renal failure who will not progress toward the akin 3 level

J. Maizel, M. Wetzstein, D. Titeca, L. Kontar, F. Brazier, B. De Cagny, A. Riviere, T. Soupison, M. Joris, M. Slama

P209 - A worldwide multicentre evaluation of acute kidney injury in septic and non-septic critically ill patients: the intensive care over nations (icon) audit

E. Peters, H. Njimi, P. Pickkers, J. L. Vincent

P210 - Does enhanced recovery after surgery reduce the incidence of acute kidney injury in those undergoing major gynae-oncological surgery?

M. Waraich , J. Doyle, T. Samuels, L. Forni

P211 - Identification of risk factors for the development of acute kidney injury after lower limb arthroplasty

N. Desai, R. Baumber, P. Gunning, A. Sell

P212 - Incidences and associations of acute kidney injury after major trauma

S. Lin, H. Torrence, M. O’Dwyer, C. Kirwan, J. Prowle

P213 - Acute kidney injury of major trauma patients

T Kim

P214 - Trajectory of serum creatinine after major surgery and the diagnosis of acute kidney injury

M. E. O’Connor, R. W. Hewson, C. J. Kirwan, R. M. Pearse, J. Prowle

P215 - Epidemiology of acute kidney injury after cardiac surgery. A single center retrospective study

S. Hanoura , A. Omar, H. Othamn, S. Sudarsanan , M. Allam, M. Maksoud, R. Singh, A. Al Khulaifi

P216 - Post-operative acute kidney injury after major non-cardiac surgery and its association with death in the following year

M. E. O’Connor, R. W. Hewson, C. J. Kirwan, R. M. Pearse, J. Prowle

P217 - Factors affecting acute renal failure in intensive care unit and effect of these factors on mortality

O. Uzundere, D. Memis , M. Ýnal, A. , N. Turan

P218 - Results of the live kidney transplantations according to national data of turkish organ and tissue information system

M. A. Aydin, H. Basar, I. Sencan, A. Kapuagasi, M. Ozturk, Z. Uzundurukan, D. Gokmen, A. Ozcan, C. Kaymak

P219 - Anaesthesia procedure and intensive therapy in patients with neck phlegmon

V. A. Artemenko, A. Budnyuk

P220 - Nasal high flow oygen for acute respiratory failure: a systematic review

R. Pugh , S. Bhandari

P221 - Setting optimal flow rate during high flow nasal cannula support: preliminary results

T. Mauri, C. Turrini, T. Langer, P. Taccone, C. A. Volta, C. Marenghi, L. Gattinoni, A. Pesenti

P222 - Dose to dose consistency across two different gas flow rates using cystic fibrosis and normal adult breathing profiles during nasal high flow oxygen therapy

L. Sweeney, A . O’ Sullivan, P. Kelly, E. Mukeria, R. MacLoughlin

P223 - Final results of an evaluation of airway medix closed suction system compared to a standard closed suction system

M. Pfeffer, J. T. Thomas, G. B. Bregman, G. K. Karp, E. K. Kishinevsky, D. S. Stavi, N. A. Adi

P224 - Different cuff materials and different leak tests - one size does not fit all

T. Poropat, R. Knafelj

P225 - Observational study on the value of the cuff-leak test and the onset of upper airway obstruction after extubation

E. Llopart, M. Batlle, C. De Haro, J. Mesquida, A. Artigas

P226 - A device for emergency transtracheal lung ventilation

D. Pavlovic, L. Lewerentz, A. Spassov, R. Schneider

P227 - Long-term outcome and health-related quality of life in patients discharged from the intensive care unit with a tracheostomy and with or without prolonged mechanical ventilation

S. De Smet, S. De Raedt, E. Derom, P Depuydt, S. Oeyen, D. Benoit, J. Decruyenaere

P228 - Ultrasound-guided percutaneous dilational tracheostomy versus bronchoscopy-guided percutaneous dilational tracheostomy in critically ill patients (trachus): a randomized clinical trial

A. Gobatto, B. Bese, P. Tierno, L. Melro, P. Mendes, F. Cadamuro, M. Park, L. M. Malbouisson

P229 - Is it safe to discharge patients with tracheostomy from the ICU to the ward?

B. C. Civanto, J. L. Lopez, A. Robles, J. Figueira, S. Yus, A. Garcia

P230 - The application of tracheostomy in children in ICU

A. Oglinda, G. Ciobanu, C. Oglinda, L. Schirca, T. Sertinean, V. Lupu

P231 - The impact of passive humidifiers on aerosol drug delivery during mechanical ventilation

P. Kelly, A. O’Sullivan, L. Sweeney, R. MacLoughlin

P232 - Evaluation of vibrating mesh and jet nebuliser performance at two different attachment setups in line with a humidifier nebuliser system

A. O’Sullivan, P. Kelly, L. Sweeney, E. Mukeria, M. Wolny , R. MacLoughlin

P233 - Psv-niv versus cpap in the treatment of acute cardiogenic pulmonary edema

A. Pagano, F. Numis, G. Vison, L. Saldamarco, T. Russo, G. Porta, F. Paladino

P234 - Noninvasive ventilation in patients with haematologic malignancy: a retrospective review

C. Bell, J. Liu, J. Debacker, C. Lee, E. Tamberg, V. Campbell, S. Mehta

P235 - Use of non-invasive ventilation in infectious diseases besides classical indications

A. Silva-Pinto, A. Sarmento, L. Santos

P236 - The impact of fragility on noninvasive mechanical ventilation application and results in the ICU

Ý. Kara, F. Yýldýrým, A. Zerman, Z. Güllü, N. Boyacý, B. Basarýk Aydogan, Ü. Gaygýsýz, K. Gönderen, G. Arýk, M. Turkoglu, M. Aydogdu, G. Aygencel, Z. Ülger, G. Gursel

P237 - Effects of metabolic alkalosis on noninvasive ventilation success and ICU outcome in patients with hypercapnic respiratory failure

N. Boyacý, Z. Isýkdogan, Ö. Özdedeoglu, Z. Güllü, M. Badoglu, U. Gaygýsýz, M. Aydogdu, G. Gursel

P238 - Asynchrony index and breathing patterns of acute exacerbation copd patients assisted with noninvasive pressure support ventilation and neurally adjusted ventilatory assist

N. Kongpolprom, C. Sittipunt

P239 - High frequency jet ventilation for severe acute hypoxemia

A. Eden, Y. Kokhanovsky, S. Bursztein – De Myttenaere, R. Pizov

P240 - HFOV revisited: a 7 year retrospective analysis of patients receiving HFOV who met oscillate trial entry criteria

L. Neilans, N. MacIntyre

P241 - Implementation of a goal-directed mechanical ventilation order set driven by respiratory therapists can improve compliance with best practices for mechanical ventilation

M. Radosevich, B. Wanta, V. Weber, T. Meyer, N. Smischney, D. Brown, D. Diedrich

P242 - A reduction in tidal volumes for ventilated patients on ICU calculated from IBW. can it minimise mortality in comparison to traditional strategies?

A . Fuller, P. McLindon, K. Sim

P243 - Predictive value of lung aeration scoring using lung ultrasound in weaning failure

M. Shoaeir, K. Noeam, A. Mahrous, R. Matsa, A. Ali

P244 - Conventional versus automated weaning from mechanical ventilation using SmartCare™

C. Dridi, S. Koubaji, S. Kamoun, F. Haddad, A. Ben Souissi, B. Laribi, A. Riahi, M. S. Mebazaa

P245 - Ultrasonographic evaluation protocol for weaning from mechanichal ventilation

A. Pérez-Calatayud, R. Carrillo-Esper, A. Zepeda-Mendoza, M. Diaz-Carrillo, E. Arch-Tirado

P246 - Diaphragm ultrasonography: a method for weaning patients from mechanical ventilation

S. Carbognin, L. Pelacani, F. Zannoni, A. Agnoli, G. Gagliardi

P247 - Dorsal diaphragmatic excursion tracks transpulmonary pressure in ventilated ARDS patients: a potential non-invasive indicator of lung recruitment?

R. Cho, A. Adams , S. Lunos, S. Ambur, R. Shapiro, M. Prekker

P248 - Pulse oximetry in the icu patient: is the perfusion index of any value?

M. Thijssen, L. Janssen, N. Foudraine

P249 - Ventilation is a better assessment of respiratory status than EtCO2

C. J. Voscopoulos, J. Freeman

P250 - Evaluation of the relationship between non-invasive minute ventilation and end-tidal CO2 in patients undergoing general vs spinal anesthesia

C. J. Voscopoulos, J. Freeman, E. George

P251 - Respiratory volume monitoring provides early warning of respiratory depression and can be used to reduce false alarms in non-intubated patients

C. J. Voscopoulos, D. Eversole, J. Freeman, E. George

P252 - P/i index: a predictive edi-derived weaning index during nava

S. Muttini, R. Bigi, G. Villani, N. Patroniti

P253 - Adequacy of ventilation in patients receiving opioids in the post anesthesia care unit: minute ventilation versus respiratory rate

G. Williams, C. J. Voscopoulos, J. Freeman, E. George

P254 - Comparison of regional and global expiratory time constants measured by electrical impedance tomography (EIT)

A. Waldmann, S. Böhm, W. Windisch, S. Strassmann, C. Karagiannidis

P255 - Electrical impedance tomography: robustness of a new pixel wise regional expiratory time constant calculation

A. Waldmann, S. Böhm, W. Windisch, S. Strassmann, C. Karagiannidis

P256 - Validation of regional and global expiratory time constant measurement by electrical impedance tomography in ards and obstructive pulmonary diseases

C. K. Karagiannidis, A. W. Waldmann, S. B. Böhm, S. Strassmann, W. W. Windisch

P257 - Transpulmonary pressure in a model with elastic recoiling lung and expanding chest wall

P. Persson, S. Lundin, O. Stenqvist

P258 - Lactate in pleural and abdominal effusion

G. Porta, F. Numis, C. S. Serra, A. P. Pagano, M. M. Masarone, L. R. Rinaldi, A. A. Amelia, M. F. Fascione, L. A. Adinolfi, E. R. Ruggiero

P259 - Outcome of patients admitted to the intensive care with pulmonary fibrosis

F. Asota, K. O’Rourke, S. Ranjan, P. Morgan

P260 - Sedation and analgesia practice in extra-corporeal membrane oxygenation (ECMO)-treated patients with acute respiratory distress syndrome (ARDS): a retrospective study

J. W. DeBacker, E. Tamberg, L. O’Neill, L. Munshi, L. Burry, E. Fan, S. Mehta

P261 - Characteristics and outcomes of patients deemed not eligible when referred for veno-venous extracorporeal membrane oxygenation (vv-ECMO)

S. Poo, K. Mahendran, J. Fowles, C. Gerrard, A. Vuylsteke

P262 - The SAVE SMR for veno-arterial ECMO

R. Loveridge, C. Chaddock, S. Patel, V. Kakar, C. Willars, T. Hurst, C. Park, T. Best, A. Vercueil, G. Auzinger

P263 - A simplified score to predict early (48 h) mortality in patients being considered for VA-ECMO

A. Borgman, A. G. Proudfoot, E. Grins, K. E. Emiley, J. Schuitema, S. J. Fitch, G. Marco, J. Sturgill, M. G. Dickinson, M. Strueber, A. Khaghani, P. Wilton, S. M. Jovinge

P264 - Lung function six months post extra corporeal membrane oxygenation (ECMO) for severe acute respiratory failure in adult survivors

C. Sampson, S. Harris-Fox

P265 - Bicarbonate dialysis removes carbon dioxide in hypoventilated rodents.

M. E. Cove, L. H. Vu, A. Sen, W. J. Federspiel, J. A. Kellum

P266 - Procalcitonin as predictor of primary graft dysfunction and mortality in post-lung transplantation

C. Mazo Torre, J. Riera, S. Ramirez, B. Borgatta, L. Lagunes, J. Rello

P267 - New molecular biomarkers of acute respiratory distress syndrome in abdominal sepsis

A. K. Kuzovlev, V. Moroz, A. Goloubev, S. Polovnikov, S. Nenchuk

P268 - Tight junction’s proteins claudin -5 and regulation by tnf in experimental murine lung injury model of ali/ards

V. Karavana, C. Glynos, A. Asimakos, K. Pappas, C. Vrettou, M. Magkou, E. Ischaki, G. Stathopoulos, S. Zakynthinos

P269 - Cell counts in endobronchial aspirate to assess airway inflammation in ARDS patients: a pilot study

S. Spadaro, I. Kozhevnikova, F. Dalla Corte, S. Grasso, P. Casolari, G. Caramori, C. Volta

P270 - Epidemiological and clinical profile of patients with acute respiratory distress syndrome in the surgical intensive care unit surgical, hospital JRA, Antananarivo

T. Andrianjafiarinoa, T. Randriamandrato, T. Rajaonera

P271 - Effect of high PEEP after recruitment maneuver on right ventricular function in ARDS. Is it good for the lung and for the heart?

S. El-Dash, ELV Costa, MR Tucci, F Leleu, L Kontar, B. De Cagny, F. Brazier, D. Titeca, G. Bacari-Risal, J. Maizel, M. Amato, M. Slama

P272 - Effect of recruitment maneuver on left ventricular systolic strain

P. Mercado, J. Maizel, L. Kontar, D. Titeca, F. Brazier, A. Riviere, M. Joris, T. Soupison, B. De Cagny, S. El Dash, M. Slama

P273 - Inhaled nitric oxide – is switching supplier cost effective?

Remmington, A. Fischer, S. Squire, M. Boichat

P274 - Epidemiological study of severe acute pancreatitis in Japan, comparison of the etiology and the patient outcomes on 1159 patients.

H. Honzawa, H. Yasuda, T. Adati, S. Suzaki, M. Horibe, M. Sasaki, M. Sanui

P275 - Extracorporeal liver support therapy. Experience in an intensive care unit

R. Marinho, J. Daniel, H. Miranda, A. Marinho

P276 - Accuracy of mortality prediction models in acute versus acute-on-chronic liver failure in the intensive care setting

K. Milinis, M. Cooper, G. R. Williams, E. McCarron, S. Simants, I. Patanwala, I. Welters

P277 - Risk of coronary artery disease in patients with chronic liver disease: a population based cohort study

Y. Su

P278 - 20 years of liver transplantation in Santiago de Compostela (Spain). Experience review

J. Fernández Villanueva, R. Fernández Garda, A. López Lago, E. Rodríguez Ruíz, R. Hernández Vaquero, S. Tomé Martínez de Rituerto, E. Varo Pérez

P279 - Diarrhea is a risk factor for liver injury and may lead to intestinal failure associated liver disease in critical illness

N. Lefel, F. Schaap, D. Bergmans, S. Olde Damink, M. Van de Poll

P280 - Bowel care on the intensive care unit: constipation guideline compliance and complications

K. Tizard, C. Lister, L. Poole

P281 - Malnutrition assessed by phase angle determines outcomes in low risk cardiac surgery patients

D. Ringaitiene, D. Gineityte, V. Vicka, I. Norkiene, J. Sipylaite

P282 - Preoperative fasting times in an irish hospital

A. O’Loughlin, V. Maraj, J. Dowling

P283 - Costs and final outcome of early x delayed feeding in a private Brazil ICU

M. B. Velasco, D. M. Dalcomune, E. B. Dias, S. L. Fernandes

P284 - Can ventilator derived energy expenditure measurements replace indirect calorimetry?

T. Oshima, S. Graf, C. Heidegger, L. Genton, V. Karsegard, Y. Dupertuis, C. Pichard

P285 - Revisiting the refeeding syndrome: results of a systematic review

N. Friedli, Z. Stanga, B. Mueller, P. Schuetz

P286 - Compliance with the new protocol for parenteral nutrition in our ICU

L. Vandersteen, B. Stessel, S. Evers, A. Van Assche, L. Jamaer, J. Dubois

P287 - Nutrition may be another treatment in the intensive care unit where less is more?

R. Marinho, H. Castro, J. Moura, J. Valente, P. Martins, P. Casteloes, C. Magalhaes, S. Cabral, M. Santos, B. Oliveira, A. Salgueiro, A. Marinho

P288 - Should we provide more protein to critically ill patients?

R. Marinho, M. Santos, E. Lafuente, H. Castro, S. Cabral, J. Moura, P. Martins, B. Oliveira, A. Salgueiro, S. Duarte, S. Castro, M. Melo, P. Casteloes, A. Marinho

P289 Protein provision in an adult intensive care unit

S. Gray

P290 - Prevalence and clinical outcomes of vitamin d deficiency in the medical critically ill patients in Songklanagarind hospital

K. Maipang, R. Bhurayanontachai

P291 - Vitamin d deficiency strongly predicts adverse medical outcome across different medical inpatient populations: results from a prospective study

L. G. Grädel, P. Schütz

P292 - Omega-3 fatty acids in patients undergoing cardiac surgery: a systematic review and meta-analysis

P. Langlois, W. Manzanares

P293 - Can 5-hydroxytriptophan prevent post-traumatic stress disorder in critically ill patients?

R. Tincu, C. Cobilinschi, D. Tomescu, Z. Ghiorghiu, R. Macovei

P294 - Parenteral selenium in the critically ill: an updated systematic review and meta-analysis

W. Manzanares, P. Langlois, M. Lemieux, G. Elke, F. Bloos, K. Reinhart, D. Heyland

P295 - Probiotics in the critically ill: an updated systematic review and meta-analysis

P. Langlois, M. Lemieux, I. Aramendi, D. Heyland, W. Manzanares

P296 - Diabetes with hyperglycemic crisis episodes may be associated with higher risk of pancreatic cancer: a population-based cohort study

Y. Su

P297 - Incidence of hypoglycemia in an intensive care unit depending on insulin protocol

R. Marinho, N. Babo, A. Marinho

P298 - Severity of the diseases is two-dimensionally correlated to blood glucose, including blood glucose variability, especially in moderately to severely ill patients with glucose intolerance.

M. Hoshino, Y. Haraguchi, S. Kajiwara, T. Mitsuhashi, T. Tsubata, M. Aida

P299 - A study of glycemic control by subcutaneous glargine injection transition from continuous regular insulin infusion in critically ill patients

T. Rattanapraphat, R. Bhurayanontachai, C. Kongkamol, B. Khwannimit

P300 - Glycemic control in Portuguese intensive care unit

R. Marinho, M. Santos, H. Castro, E. Lafuente, A. Salgueiro, S. Cabral, P. Martins, J. Moura, B. Oliveira, M. Melo, B. Xavier, J. Valente, C. Magalhaes, P. Casteloes, A. Marinho

P301 - Impact of hyperglycemia duration on the day of operation on short-term outcome of cardiac surgery patients

D. Moisidou, F. Ampatzidou, C. Koutsogiannidis, M. Moschopoulou, G. Drossos

P302 - Lactate levels in diabetic ketoacidosis patients at ICU admissions

G. Taskin, M. Çakir, AK Güler, A. Taskin, N. Öcal, S. Özer, L. Yamanel

P303 - Intensive care implications of merging heart attack centre units in London

J. M. Wong, C. Fitton, S. Anwar, S. Stacey

P304 - Special characteristics of in-hospital cardiac arrests

M. Aggou, B. Fyntanidou, S. Patsatzakis, E. Oloktsidou, K. Lolakos, E. Papapostolou, V. Grosomanidis

P305 - Clinical evaluation of ICU-admitted patients who were resuscitated in the general medicine ward

S. Suda , T. Ikeda, S. Ono, T. Ueno, Y. Izutani

P306 - Serious game evaluation of a one-hour training basic life support session for secondary school students: new tools for future bystanders

S. Gaudry, V. Desailly, P. Pasquier, PB Brun, AT Tesnieres, JD Ricard, D. Dreyfuss, A. Mignon

P307 - Public and clinical staff perceptions and knowledge of CPR compared to local and national data

J. C White, A. Molokhia, A. Dean, A. Stilwell, G. Friedlaender

P308 Dispatcher-assisted telephone cardiopulmonary resuscitation using a French-language compression-ventilation pediatric protocol

M. Peters, S. Stipulante, A. Delfosse, AF Donneau, A. Ghuysen

P309 Dantrolene versus amiodarone for resuscitation – an experimental study

C. Feldmann, D. Freitag, W. Dersch, M. Irqsusi, D. Eschbach, T. Steinfeldt, H. Wulf, T. Wiesmann

P310 Long term survival and functional neurological outcome in comatose survivors undergoing therapeutic hypothermia

N. Kongpolprom, J. Cholkraisuwat

P311 Impact of kidney disease on mortality and neurological outcome in out-of-hospital cardiac arrest: a prospective observational study

S. Beitland , E. Nakstad, H. Stær-Jensen , T. Drægni , G. Andersen , D. Jacobsen , C. Brunborg, B. Waldum-Grevbo , K. Sunde

P312 ICU dependency of patients admitted after primary percutaneous coronary intervention (PPCI) following out of the hospital cardiac arrest

K. Hoyland, D. Pandit

P313 Prognostic indicators and outcome prediction model for patients with return of spontaneous circulation from cardiopulmonary arrest: comprehensive registry of in-hospital intensive care on OHCA survival (critical) study in Osaka, Japan

K. Hayakawa

P314 Cerebral oxygen saturation during resuscitation in a porcine model of cardiac arrest

E. Oloktsidou, K. Kotzampassi, B. Fyntanidou, S. Patsatzakis, L. Loukipoudi, E. Doumaki, V. Grosomanidis

P315 Presumption of cardiopulmonary resuscitation for sustaining cerebral oxidation using regional cerebral saturation of oxygen: observational cohort study (press study)

H. Yasuda

P316 EEG reactivity in patients after cardiac arrest: a close look at stimuli

MM Admiraal, M. Van Assen, MJ Van Putten, M. Tjepkema-Cloostermans, AF Van Rootselaar, J. Horn

P317 Prognostic value of neuron-specific enolase after cardiac arrest

F. Ragusa, A. Marudi , S. Baroni, A. Gaspari, E. Bertellini

P318 Correlation between electroencephalographic findings and serum neuron specific enolase with outcome of post cardiac arrest patients

A. Taha, T. Abdullah, S. Abdel Monem

P319 Introduction of a targeted temperature management strategy following cardiac arrest in a district general hospital intensive care unit.

S. Alcorn, S. McNeill, S. Russell

P320 The evolution of cerebral oxygen saturation in post-cardiac arrest patients treated with therapeutic hypothermia

W. Eertmans, C. Genbrugge, I. Meex, J. Dens, F. Jans, C. De Deyne

P321 Prognostic factors and neurological outcomes of therapeutic hypothermia in comatose survivors from cardiac arrest: 8-year single center experience

J. Cholkraisuwat, N. Kongpolprom

P322 Adherence to targeted temperature management after out of hospital cardiac arrest

B. Avard, R. Burns

P323 Implementation of a therapeutic hypothermia protocol for comatose survivors of out-of-hospital cardiac arrest.

A. Patarchi, T. Spina

P324 Factors associated with ventilator weaning after targeted temperature management for cardiac arrest patients in japan

H. Tanaka, N. Otani, S. Ode, S. Ishimatsu

P325 Differential activation of c-fos in paraventricular nuclei of the hypothalamus and thalamus of the rat following myocardial infarction

J. Cho, J. B. Moon, C. W. Park, T. G. Ohk, M. C. Shin, M. H. Won

P326 Monitoring of cTroponin I in patients with acute ischemic stroke - predictor of inhospital mortality

S. Dakova, Z. Ramsheva, K. Ramshev

P327 Hyperthermic preconditioning severely accelerates neuronal damage in the gerbil ischemic hippocampal dentate gyrus via decreasing sods expressions

J. Cho, J. B. Moon, C. W. Park, T. G. Ohk, M. C. Shin

P328 Failure in neuroprotection of remote limb ischemic post conditioning in the hippocampus of a gerbil model of transient cerebral ischemia

J. Cho, J. B. Moon, C. W. Park, T. G. Ohk, M. C. Shin

P329 Brain death and admission diagnosis in neurologic intensive care unit, a correlation?

A Marudi, S Baroni, A Gaspari, E Bertellini

P330 Brain magnetic resonance imaging findings in patients with septic shock

G. Orhun, E. Senturk, P. E. Ozcan, S. Sencer, C. Ulusoy, E. Tuzun, F . Esen

P331 Benefits of L-carnitine in valproic acid induced encephalopathy

R. Tincu, C. Cobilinschi, D. Tomescu, Z. Ghiorghiu, R. Macovei

P332Automatic analysis of EEG reactivity in comatose patients

M. Van Assen, M. M. Admiraal, M. J. Van Putten, M. Tjepkema-Cloostermans, A. F. Van Rootselaar, J. Horn

P333 Usefulness of common ICU severity scoring systems in predicting outcome after spontaneous intracerebral hemorrhage

M. Fallenius, M. B. Skrifvars, M. Reinikainen, S. Bendel, R. Raj

P334 Evalution of patients with suspected subarachnoid haemorrhage and negative ct imaging

M. Abu-Habsa, C. Hymers, A. Borowska, H. Sivadhas, S. Sahiba, S. Perkins

P335 Timing of endovascular and surgical treatment for aneurysmal subarachnoid haemorrhage: early but not so fast.

J. Rubio, J. A. Rubio, R. Sierra

P336 Red blood cell transfusion in aneurysmal subarachnoid hemorrhage – the Sahara cohort study

S. English, M. Chasse, A. Turgeon, F. Lauzier, D. Griesdale, A. Garland, D. Fergusson, R. Zarychanski, A. Tinmouth, C. Van Walraven, K. Montroy, J. Ziegler, R. Dupont Chouinard, R. Carignan, A. Dhaliwal, C. Lum, J. Sinclair, G. Pagliarello, L. McIntyre

P337 - Aneurysmal subarachnoid hemorrhage and anemia: a canadian multi-centre retrospective cohort study

S. English, M. Chasse, A. Turgeon, F. Lauzier, D. Griesdale, A. Garland, D. Fergusson, R. Zarychanski, A. Tinmouth, C. Van Walraven, K. Montroy, J. Ziegler, R. Dupont Chouinard, R. Carignan, A. Dhaliwal, C. Lum, J. Sinclair, G. Pagliarello, L. McIntyre

P338 - Does the neutrophil-to-lymphocyte (NLR) ratio predict symptomatic vasospasm or delayed cerebral ischemia (DCI) after aneurysmal subarachnoid haemorrhage (SAH)?

T. Groza, N. Moreau, D. Castanares-Zapatero, P. Hantson

P339 - ICU-acquired infections in aneurysmal subarachnoid hemorrhage patients: impact on ICU and hospital length of stay

M. Carbonara , F. Ortolano, T. Zoerle, S. Magnoni, S. Pifferi, V. Conte, N. Stocchetti

P340 - Cerebral metabolic effects of normobaric hyperoxia during the acute phase of aneurysmal subarachnoid hemorrhage

L. Carteron, T. Suys, C. Patet, H. Quintard, M. Oddo

P341 - Postoperative care for elective craniotomy: where is best done?

J. A. Rubio, J. Rubio, R. Sierra

P342 - 5-year follow-up of patients after transplantation of organs from donors from neurocritical care

V. Spatenkova, E. Pokorna, P. Suchomel

P343 - Evaluation of levetiracetam pharmacokinetics after severe traumatic brain injury in neurocritical care patients at a level one trauma center

N. Ebert, J. Jancik, H. Rhodes

P344 - Model based time series cluster analysis to determine unique patient states in traumatic brain injury

T. Bylinski, C. Hawthorne, M. Shaw, I. Piper, J. Kinsella

P345 - Brain compartment monitoring capabilities from ICP to BI (bioimpedance) during HS (hypertonic saline) administration. State of art simulation outcome depending on brain swelling type

A. K. Kink , I. R. Rätsep

P346 - Transfusion of red blood cells in patients with traumatic brain injury admitted to Canadian trauma health centers: a multicenter cohort study

A. Boutin, L. Moore, M. Chasse, R. Zarychanski, F. Lauzier, S. English, L. McIntyre, J. Lacroix, D. Griesdale, P. Lessard-Bonaventure, A. F. Turgeon

P347 - Hemoglobin thresholds and red blood cell transfusions in adult patients with moderate or severe traumatic brain injury: a retrospective cohort study

A. Boutin, L. Moore, R. Green, P. Lessard-Bonaventure, M. Erdogan, M. Butler, F. Lauzier, M. Chasse, S. English, L. McIntyre, R. Zarychanski, J. Lacroix, D. Griesdale, P. Desjardins, D. A. Fergusson, A. F. Turgeon

P348 - Characteristics of patients with gunshot wounds to the head - an observational Brazilian study

B. Goncalves, B. Vidal, C. Valdez, A. C. Rodrigues, L. Miguez, G. Moralez

P349 - Base excess as predictor for ICU admission and the injury severity in blunt trauma patients

T. Hong

P350 - Enhancement of usual emergency department care with proadrenomedullin to improve outcome prediction - Results from the multi-national, prospective, observational TRIAGE study

A. Kutz, P. Hausfater, D. Amin, T. Struja, S. Haubitz, A. Huber, B. Mueller, P. Schuetz

P351 - Developing an innovative emergency medicine point-of-care simulation programme

T. Brown, J. Collinson, C. Pritchett, T. Slade

P352 - The InSim program: an in situ simulation program for junior trainees in intensive care

M. Le Guen, S. Hellings, R. Ramsaran

P353 - Impact of excessive and inappropriate troponin testing in the emergency setting how good are we

A. Alsheikhly

P354 - The development of time tracking monitor at emergency department

T. Abe

P355 - Role of focussed echocardiography in emergency assessment of syncope

L. Kanapeckaite, M. Abu-Habsa, R. Bahl

P356 - Insertion of an open-ended 14-gauge catheter through the chest wall causes a significant pneumothorax in a self-ventilating swine model

M. Q Russell, K. J. Real, M. Abu-Habsa , R. M. Lyon, N. P. Oveland

P357 - Ez-io® intraosseous access teaching in the workplace using a mobile ‘tea trolley’ training method

J. Penketh, M. Mcdonald, F. Kelly

P358 - Black widow envenomation in Saudi Arabia: a prospective observational case series

M. Alfafi, S. Alsolamy, W. Almutairi, B. Alotaibi

P359 - Mechanical ventilation in patients with overdose not yet intubated on icu admission

A. E. Van den Berg, Y. Schriel, L. Dawson, I. A. Meynaar

P360 - Central nervous system depressants poisoning and ventilator associated pneumonia: an underrated risk factor in toxicological intensive care unit

H. Talaie

P361 - Acute barium intoxication treated with hemodiafiltration

D. Silva, S. Fernandes, J. Gouveia, J. Santos Silva

P362 - Major trauma presenting to the emergency department. the spectrum of cycling injuries in Ireland

J. Foley, A. Kaskovagheorgescu, D. Evoy, J. Cronin, J. Ryan

P363 - Burns from French military operations: a 14-year retrospective observational analysis.

M. Huck, C. Hoffmann, J. Renner, P. Laitselart, N. Donat, A. Cirodde, J. V. Schaal, Y. Masson, A. Nau, T. Leclerc

P364 - A comparison of mortality scores in burns patients on the intensive care unit.

O. Howarth, K. Davenport, P. Jeanrenaud, S. Raftery

P365 - Clasification of pain and its treatment and an intensive care rehabiliation clinic

P. MacTavish, H. Devine, J. McPeake, M. Daniel, J. Kinsella, T. Quasim

P366 - Pain management adequacy in critical care areas ,the process and the barriers perceived by critical care nurses

S. Alrabiee, A. Alrashid , S. Alsolamy

P367 - Pain assessment in critically ill adult patients: validation of the Turkish version of the critical-care pain observation tool

O. Gundogan, C. Bor, E. Akýn Korhan, K. Demirag , M. Uyar

P368 - An audit of pain and sedation assessments in the intensive care unit: recommendations for clinical practice

F. Frame, C. Ashton, L. Bergstrom Niska

P369 - Impact of pharmaceutical care on treatment of pain and agitation in medical intensive care unit

P. Dilokpattanamongkol, T. Suansanae, C. Suthisisang, S. Morakul, C. Karnjanarachata, V. Tangsujaritvijit

P370 - Agitation in trauma ICU, prevention and outcome

S. Mahmood, H. Al Thani, A. Almenyar

P371 Correlation between percentages of ventilated patients developed vap and use of sedative agents in icu patients.

A. Vakalos , V. Avramidis

P372 - Improving recording of sedation events in the Emergency Department: The implementation of the SIVA International Taskforce adverse event reporting tool for procedural sedation

R. Sharvill, J. Penketh

P373 - Impact of sedative drug use on the length of mechanical ventilation

S. E. Morton, Y. S. Chiew, C. Pretty, J. G. Chase, G. M. Shaw

P374 - Co-administration of nitric oxide and sevoflurane using anaconda

R. Knafelj, P. Kordis

P375 - A retrospective study of the use of Dexmedetomidine in an oncological critical care setting

S. Patel, V. Grover

P376 - Dexmedetomidine and posttraumatic stress disorder incidence in alcohol withdrawal icu patients

I. Kuchyn, K. Bielka

P377 - Hemodynamic effects of dexmedetomidine in a porcine model of septic shock

Z. Aidoni, V. Grosomanidis, K. Kotzampassi, G. Stavrou, B. Fyntanidou, S. Patsatzakis, C. Skourtis

P378 - Ketamine for analgosedation in severe hypoxic respiratory failure

S. D. Lee, K. Williams, I. D. Weltes

P379 - Madness from the moon? lunar cycle and the incidence of delirium on the intensive care unit

S. Berhane, C. Arrowsmith, C. Peters, S. Robert

P380 - Impaired dynamic cerebral autoregulation after coronary artery bypass grafting and association with postoperative delirium

J. Caldas, R. B. Panerai, T. G. Robinson, L. Camara, G. Ferreira, E. Borg-Seng-Shu, M. De Lima Oliveira, N. C. Mian, L. Santos, R. Nogueira, S. P. Zeferino, M. Jacobsen Teixeira, F. Galas, L. A. Hajjar

P381 - Risk factors predicting prolonged intensive care unit length of stay after major elective surgery.

P. Killeen, M. McPhail, W. Bernal, J. Maggs, J. Wendon, T. Hughes

P382 - Systemic inflammatory response syndrome criteria and hospital mortality prediction in a brazilian cohort of critically ill patients

L. U. Taniguchi, E. M. Siqueira, J. M. Vieira Jr, L. C. Azevedo

P383 - Evaluating the efficacy of a risk predictor panel in identifying patients at elevated risk of morbidity following emergency admission

A. N. Ahmad, M. Abu-Habsa, R. Bahl, E. Helme, S. Hadfield, R. Loveridge

P384 - A retrospective comparison of outcomes for elective surgical patients admitted post-operatively to the critical care unit or general ward

J. Shak, C. Senver, R. Howard-Griffin

P385 - Effect of obesity on mortality in surgical critically ill patients.

P. Wacharasint, P. Fuengfoo, N. Sukcharoen, R. Rangsin

P386 - The national early warning score (news) reliably improves adverse clinical outcome prediction in community-acquired pneumonia - results from a 6 year follow-up

D. Sbiti-Rohr, P. Schuetz

P387 - Clinical usefulness of the charlson¡¯s weighted index of comorbidities _as prognostic factor in patients with prolonged acute mechanical ventilation

H. Na, S. Song, S. Lee, E. Jeong, K. Lee

P388 - Comparison of mortality prediction scoring systems in patients with cirrhosis admitted to general intensive care unit

M. Cooper, K. Milinis, G. Williams, E. McCarron, S. Simants, I. Patanwala, I. D. Welters

P389 - Impact of admission source and time of admission on outcome of pediatric intensive care patients: retrospective 15 years study

E. Zoumpelouli, EA Volakli, V. Chrysohoidou, S. Georgiou, K. Charisopoulou, E. Kotzapanagiotou, V. Panagiotidou, K. Manavidou, Z. Stathi, M. Sdougka

P390 - Heart rate variability and outcomes prediction in critical illness

N. Salahuddin, B. AlGhamdi, Q. Marashly, K. Zaza, M. Sharshir, M. Khurshid, Z. Ali, M. Malgapo, M. Jamil, A. Shafquat, M. Shoukri, M. Hijazi

P391 - The incidence and outcome of hyperlactatemia in the post anaesthesia care unit

T. Abe, S. Uchino, M. Takinami

P392 - Correlation between arterial blood gas disturbances and arterial lactate levels during hospitalization and outcome in critically septic patients

N. R. Rangel Neto, S. Oliveira, F. Q. Reis, F. A. Rocha

P393 - External validation of saps 3 and mpm iii scores in 48,816 patients from 72 brazilian icus

G. Moralez, K. Ebecken, L. S. Rabello, M. F. Lima, R. Hatum, F. V. De Marco, A. Alves, J. E. Pinto, M. Godoy, P. E. Brasil, F. A. Bozza, J. I. Salluh, M. Soares

P394 - The frailty penalty: pre-admission functional status confounds mortality prediction models in critically ill patients

J. Krinsley, G. Kang

P395 - ‘sooner rather than later”: how delayed discharge from critical care leads to increased out of hours discharges and subsequent increase in in-hospital mortality.

J. Perry, H. Hines

P396 - Identifying poor outcome patient groups in a resource-constrained critical care unit

K. M. Wilkinson, C. Tordoff, B. Sloan, M. C. Bellamy

P397 - Effects of icu weekend admission and discharge on mortality.

E. Moreira, F. Verga, M. Barbato, G. Burghi

P398 - Organizational factors, outcomes and resource use in 9,946 cancer patients admitted to 70 ICUs

M Soares, U. V. Silva, L. C. Azevedo, A. P. Torelly, J. M. Kahn, D. C. Angus, M. F. Knibel, P. E. Brasil, F. A. Bozza, J. I. Salluh

P399 - Evaluation of oncological critically ill patients, severity score and outcome compared to not oncological in a particular hospital cti.

M. B. Velasco, D. M. Dalcomune

P400 - Outcomes of patients admitted to a large uk critical care department with palliative oncological diagnoses

R. Marshall, T. Gilpin, A. Tridente, A. Raithatha

P401 - Predictors of mortality in febrile neutropenic patients with haematological malignancies admitted to an intensive care unit of a cancer center

D. Mota, B. Loureiro, J. Dias, O. Afonso, F. Coelho, A. Martins, F. Faria

P402 - Patients with hematologic malignancies requiring invasive mechanical ventilation: characteristics and predictors of mortality

H. Al-Dorzi, H. Al Orainni , F. AlEid, H. Tlaygeh, A. Itani, A. Hejazi, Y. Arabi

P403 - Patient-important outcomes in randomized controlled trials in critically ill patients: a systematic review

S. Gaudry, J. Messika, J. D. Ricard, S. Guillo, B. Pasquet, E. Dubief, D. Dreyfuss, F. Tubach

P404 - Alopecia in survivors of critical illness: a qualitative study

C . Battle, K. James, P. Temblett

P405 - The impact of mental health on icu admission

L. Davies, C. Battle, C. Lynch

P406 - Cognitive impairment 5 years after ICU discharge

S. Pereira, S. Cavaco, J. Fernandes, I. Moreira, E. Almeida, F. Seabra Pereira, M. Malheiro, F. Cardoso, I. Aragão, T. Cardoso

P407 - Apache ii versus apache iv for octagenerians in medical icu

M. Fister, R. Knafelj

P408 - Outcomes of octagenarians in an indian icu

P. Muraray Govind, N. Brahmananda Reddy, R. Pratheema, E. D. Arul, J. Devachandran

P409 - Mortality and outcomes in elderly patients 80 years of age or older admitted to the icu

M. B. Velasco , D. M. Dalcomune

P410 - Octagenerians in medical icu - adding days to life or life to days?

R. Knafelj, M. Fister

P411 - The very elderly admitted to intensive care unit: outcomes and economic evaluation

N. Chin-Yee, G. D’Egidio, K. Thavorn, D. Heyland, K. Kyeremanteng

P412 - The very elderly in intensive care: relationship between acuity of illness and long-term mortality

A. G. Murchison, K. Swalwell, J. Mandeville, D. Stott

P413 - Acquired weakness in an oncological intensive care unit

I. Guerreiro

P414 - Musculoskeletal problems in intensive care unit (ICU) patients post-discharge

H. Devine, P. MacTavish, J. McPeake, T. Quasim, J. Kinsella, M. Daniel

P415 - Premorbid obesity, but not nutrition, prevents critical illness-induced muscle wasting and weakness

C. Goossens M. B. Marques, S. Derde, S. Vander Perre, T. Dufour, S. E. Thiessen, F. Güiza, T. Janssens, G. Hermans, I. Vanhorebeek, K. De Bock, G. Van den Berghe, L. Langouche

P416 - Physical outcome measures for critical care patients following intensive care unit (icu) discharge

H. Devine, P. MacTavish, T. Quasim, J. Kinsella, M. Daniel, J. McPeake

P417 - Improving active mobilisation in a general intensive care unit

B. Miles , S. Madden, H. Devine

P418 - Mobilization in patients on vasoactive drugs use – a pilot study.

M. Weiler, P. Marques, C. Rodrigues, M. Boeira, K. Brenner, C. Leães, A. Machado, R. Townsend, J. Andrade

P419 - Pharmacy intervention at an intensive care rehabilitation clinic

P. MacTavish, J. McPeake, H. Devine, J. Kinsella, M. Daniel, R. Kishore, C. Fenlon, T. Quasim

P420 - Interactive gaming is feasible and potentially increases icu patients’ motivation to be engaged in rehabilitation programs

T. Fiks, A. Ruijter, M. Te Raa, P. Spronk

P421 - Simulation-based design of a robust stopping rule to ensure patient safety

Y. S. Chiew, P. Docherty, J. Dickson, E. Moltchanova, C. Scarrot, C. Pretty, G. M. Shaw, J. G. Chase

P422 - Are daily blood tests on the intensive care unit necessary?

T. Hall, W. C. Ngu, J. M. Jack, P. Morgan

P423 - Measuring urine output in ward patients: is it helpful?

B. Avard, A. Pavli, X. Gee

P424 - The incidence of pressure ulcers in an adult mixed intensive care unit in turkey

C . Bor, E. Akin Korhan, K. Demirag, M. Uyar

P425 - Intensivist/patient ratios in closed ICUs in Alexandria, Egypt; an overview

M. Shirazy, A. Fayed

P426 - Eicu (electronic intensive care unit): impact on ALOS (average length of stay) in a developing country like India

S. Gupta, A. Kaushal, S. Dewan, A. Varma

P427 - Predicting deterioration in general ward using early deterioration indicator

E. Ghosh, L. Yang, L. Eshelman, B. Lord, E. Carlson

P428 - High impact enhanced critical care outreach - the imobile service: making a difference

E. Helme, R. Broderick, S. Hadfield, R. Loveridge

P429 - Impact of bed availability and cognitive load on intensive care unit (ICU) bed allocation: a vignette-based trial

J. Ramos, D. Forte

P430 - Characteristics of critically ill patients admitted through the emergency department

F. Yang, P. Hou

P431 - Admission to critical care: the quantification of functional reserve

J. Dudziak, J. Feeney, K. Wilkinson, K. Bauchmuller, K. Shuker, M. Faulds, A. Raithatha, D. Bryden, L. England, N. Bolton, A. Tridente

P432 - Admission to critical care: the importance of frailty

K. Bauchmuller, K Shuker, A Tridente, M Faulds, A Matheson, J. Gaynor, D Bryden, S South Yorkshire Hospitals Research Collaboration

P433 - Development of an instrument to aid triage decisions for intensive care unit admission

J. Ramos, B. Peroni, R. Daglius-Dias, L. Miranda, C. Cohen, C. Carvalho, I . Velasco, D. Forte

P434 - Using selective serotonin re-uptake inhibitors and serotonin-norepinephrine re-uptake inhibitors in critical care: a systematic review of the evidence for benefit or harm

J. M. Kelly, A. Neill, G. Rubenfeld, N. Masson, A. Min

P435 - Measuring adaptive coping of hospitalized patients with a severe medical condition:the sickness insight in coping questionnaire (sicq)

E. Boezeman, J. Hofhuis , A. Hovingh, R. De Vries, P. Spronk

P436 - Results of a national survey regarding intensive care medicine training

G. Cabral-Campello, I. Aragão, T. Cardoso

P437 - Work engagement among healthcare professionals in the intensive care unit

M. Van Mol, M. Nijkamp, E . Kompanje

P438 - Empowering the intensive care practitioners. is it a burnout ameliorating intervention?

P. Ostrowski, A. Omar

P439 - Icu patients suffer from circadian rhythm desynchronisation

K. Kiss , B. Köves, V. Csernus, Z. Molnár

P440 - Noise reduction in the ICU: feasible ?

Y. Hoydonckx, S. Vanwing, B. Stessel, A. Van Assche, L. Jamaer, J. Dubois

P441 - Accidental removal of invasive devices in the critical patient into the bed-washing. does the presence of professional nurse modify his incidence?

V. Medo, R. Galvez, J. P. Miranda

P442 - Deprivation of liberty safeguards (dols): audit of compliance in a of a 16-bed specialist cancer critical care unit.

C. Stone, T. Wigmore

P443 - Use of a modified cristal score to predict futility of critical care in the elderly

Y. Arunan, A. Wheeler, K. Bauchmuller, D. Bryden

P444 - Improvement of Referral Rate to Palliative Care for Patients with Poor Prognosis in Neurosurgical Intensive Care Unit

Y. Wong, C. Poi, C. Gu

P445 - Factors associated with limitation of life supporting care (lsc) in a medico-surgical intermediate care unit, and outcome of patients with lsc limitation: a monocentric, six-month study.

P. Molmy, N. Van Grunderbeeck, O. Nigeon, M. Lemyze, D. Thevenin, J. Mallat

P446 - Palliative care consultation and intensive care unit admission request: a cohort study

J. Ramos, M. Correa, R. T. Carvalho, D. Forte

P447 - Nursing and medicine together in postsurgical intensive care unit: situations of prognostic conflict at the end of life. our critical care nurses suffer with our medical activism?

A. Fernandez, C. McBride

P448 - End of life who may decide

E. Koonthalloor, C. Walsh

P449 - Correctly diagnosing death

A. Webber, M. Ashe, K. Smith, P. Jeanrenaud

P450 - Skin procurement performed by intensive care physicians: yes, we can.

A. Marudi , S. Baroni, F. Ragusa, E. Bertellini

P451 - Death analysis in pediatric intensive care patients

E. A. Volakli , E. Chochliourou, M. Dimitriadou, A. Violaki, P. Mantzafleri, E. Samkinidou, O. Vrani, A. Arbouti, T. Varsami, M. Sdougka

P452 - The potential impact of euthanasia on organ donation: analysis of data from belgium

J. A. Bollen, T. C. Van Smaalen, W. C. De Jongh, M. M. Ten Hoopen, D. Ysebaert, L. W. Van Heurn, W. N. Van Mook

P453 - Communication within an intensive care setting

K. Sim, A. Fuller

P454 - Development and implementation of a longitudinal communication curriculum for critical care medicine fellows

A. Roze des Ordons, P. Couillard, C. Doig

P455 - Staff-family conflict in a multi-ethnic intensive care unit

R. V. Van Keer, R. D. Deschepper, A. F. Francke, L. H. Huyghens, J. B. Bilsen

P456 - Does the source of admission to critical care affect family satisfaction?

B. Nyamaizi, C. Dalrymple, A. Molokhia, A. Dobru

P457 - A simple alternative to the family satisfaction survey (fs-icu)

E. Marrinan, A. Ankuli, A. Molokhia

P458 - A study to explore the experiences of patient and family volunteers in a critical care environment: a phenomenological analysis

J. McPeake, R. Struthers, R. Crawford , H. Devine , P. Mactavish , T. Quasim

P459 - Prevalence and risk factors of anxiety and depression in relatives of burn patients.

P. Morelli, M. Degiovanangelo, F. Lemos, V. MArtinez, F. Verga, J. Cabrera, G. Burghi

P460 - Guidance of visiting children at an adult intensive care unit (icu)

A. Rutten , S. Van Ieperen, S. De Geer, M. Van Vugt, E. Der Kinderen

P461 - Visiting policies in Italian pediatric ICUs: an update

A. Giannini, G Miccinesi, T Marchesi, E Prandi

Prognosis and improved outcomes in major depression: a review

Treatment outcomes for major depressive disorder (MDD) need to be improved. Presently, no clinically relevant tools have been established for stratifying subgroups or predicting outcomes. This literature review sought to investigate factors closely linked to outcome and summarize existing and novel strategies for improvement. The results show that early recognition and treatment are crucial, as duration of untreated depression correlates with worse outcomes. Early improvement is associated with response and remission, while comorbidities prolong course of illness. Potential biomarkers have been explored, including hippocampal volumes, neuronal activity of the anterior cingulate cortex, and levels of brain-derived neurotrophic factor (BDNF) and central and peripheral inflammatory markers (e.g., translocator protein (TSPO), interleukin-6 (IL-6), C-reactive protein (CRP), tumor necrosis factor alpha (TNFα)). However, their integration into routine clinical care has not yet been fully elucidated, and more research is needed in this regard. Genetic findings suggest that testing for CYP450 isoenzyme activity may improve treatment outcomes. Strategies such as managing risk factors, improving clinical trial methodology, and designing structured step-by-step treatments are also beneficial. Finally, drawing on existing guidelines, we outline a sequential treatment optimization paradigm for selecting first-, second-, and third-line treatments for acute and chronically ill patients. Well-established treatments such as electroconvulsive therapy (ECT) are clinically relevant for treatment-resistant populations, and novel transcranial stimulation methods such as theta-burst stimulation (TBS) and magnetic seizure therapy (MST) have shown promising results. Novel rapid-acting antidepressants, such as ketamine, may also constitute a paradigm shift in treatment optimization for MDD.

Caustic injury of the upper gastrointestinal tract: a comprehensive review

Prevention has a paramount role in reducing the incidence of corrosive ingestion especially in children, yet this goal is far from being reached in developing countries, where such injuries are largely unreported and their true prevalence simply cannot be extrapolated from random articles or personal experience. The specific pathophysiologic mechanisms are becoming better understood and may have a role in the future management and prevention of long-term consequences, such as esophageal strictures. Whereas the mainstay of diagnosis is considered upper gastrointestinal endoscopy, computed tomography and ultrasound are gaining a more significant role, especially in addressing the need for emergency surgery, whose morbidity and mortality remains high even in the best hands. The need to perform emergency surgery has a persistent long-term negative impact both on survival and functional outcome. Medical or endoscopic prevention of stricture is debatable, yet esophageal stents, absorbable or not, show promising data. Dilatation is the first therapeutic option for strictures and bougies should be considered especially for long, multiple and tortuous narrowing. It is crucial to avoid malnutrition, especially in developing countries where management strategies are influenced by malnutrition and poor clinical conditions. Late reconstructive surgery, mainly using colon transposition, offers the best results in referral centers, either in children or adults, but such a difficult surgical procedure is often unavailable in developing countries. Possible late development of esophageal cancer, though probably overemphasized, entails careful and long-term endoscopic screening.

Meta-analysis of radiofrequency ablation in combination with transarterial chemoembolization for hepatocellular carcinoma

AIM: To compare radiofrequency ablation (RFA) and transcatheter arterial chemoembolization (TACE) with RFA monotherapy in hepatocellular carcinoma (HCC).

METHODS: We searched PubMed, Medline, Embase and Chinese databases (CBMdisc and Wanfang data) for randomized controlled trails comparing RFA plus TACE and RFA alone for treatment of HCC from January 2000 to December 2012. The overall survival rate, recurrence-free survival rate, tumor progression rate, and safety were analyzed and compared. The analysis was conducted on dichotomous outcomes and the standard meta-analytical techniques were used. Pooled odds ratios (ORs) with 95%CIs were calculated using either the fixed-effects or random-effects model. For each meta-analysis, the χ² and I² tests were first calculated to assess the heterogeneity of the included trials. For P < 0.05 and I² > 50%, the assumption of homogeneity was deemed invalid, and the random-effects model was used; otherwise, data were assessed using the fixed-effects model. All statistical analysis was conducted using Review manager (version 4.2.2.) from the Cochrane collaboration.

RESULTS: Eight randomized controlled trials were identified as eligible for inclusion in this analysis and included 598 patients with 306 treated with RFA plus TACE and 292 with RFA alone. Our data analysis indicated that RFA plus TACE was associated a significantly higher overall survival rate (OR_1-year = 2.96, 95%CI: 1.84-7.74, P < 0.001; OR_2-year = 3.72, 95%CI: 1.24-11.16, P = 0.02; OR_3-year = 2.65, 95%CI: 1.81-3.86, P < 0.001) and recurrence-free survival rate (OR_3-year = 3.00, 95%CI: 1.75-5.13, P < 0.001; OR_5-year = 2.26, 95%CI: 1.43-3.57, P = 0.0004) vs that of RFA alone. The tumor progression rate in patients treated with RFA alone was higher than that of RFA plus TACE (OR = 0.60, 95%CI: 0.42-0.88, P = 0.008) and there was no significant difference on major complications between two different kinds of treatment (OR = 1.20, 95%CI: 0.31-4.62, P = 0.79). Additionally, the meta-analysis data of subgroups revealed that the survival rate was significantly higher in patients with intermediate- and large-size HCC underwent RFA plus TACE than in those underwent RFA monotherapy; however, there was no significant difference between RFA plus TACE and RFA on survival rate for small HCC.

CONCLUSION: The combination of RFA with TACE has advantages in improving overall survival rate, and provides better prognosis for patients with intermediate- and large-size HCC.

The cancer driver genes IDH1/2, JARID1C/ KDM5C, and UTX/ KDM6A: crosstalk between histone demethylation and hypoxic reprogramming in cancer metabolism

Recent studies on mutations in cancer genomes have distinguished driver mutations from passenger mutations, which occur as byproducts of cancer development. The cancer genome atlas (TCGA) project identified 299 genes and 24 pathways/biological processes that drive tumor progression (Cell 173: 371-385 e318, 2018). Of the 299 driver genes, 12 genes are involved in histones, histone methylation, and demethylation. Among these 12 genes, those encoding the histone demethylases JARID1C/KDM5C and UTX/KDM6A were identified as cancer driver genes. Furthermore, gain-of-function mutations in genes encoding metabolic enzymes, such as isocitrate dehydrogenases (IDH)1/2, drive tumor progression by producing an oncometabolite, D-2-hydroxyglutarate (D-2HG), which is a competitive inhibitor of α-ketoglutarate, O₂-dependent dioxygenases such as Jumonji domain-containing histone demethylases, and DNA demethylases. Studies on oncometabolites suggest that histone demethylases mediate metabolic changes in chromatin structure. We have reviewed the most recent findings regarding cancer-specific metabolic reprogramming and the tumor-suppressive roles of JARID1C/KDM5C and UTX/KDM6A. We have also discussed mutations in other isoforms such as the JARID1A, 1B, 1D of KDM5 subfamilies and the JMJD3/KDM6B of KDM6 subfamilies, which play opposing roles in tumor progression as oncogenes or tumor suppressors depending on the cancer cell type.

Genes involved in the removal of methyl groups from histones associated with DNA can promote or suppress tumor growth depending on the metabolic status of the cancer cell. Hyunsung Park and colleagues at the University of Seoul, South Korea, review current knowledge of two genes encoding histone demethylases which have been identified by The Cancer Genome Atlas (TCGA) project as cancer driver genes. Because these demethylase enzymes rely on cellular metabolites to function, their effect is influenced by metabolic conditions in the tumor microenvironment such as low oxygen. The mechanisms through which changes in histone methylation affect the expression of genes involved in tumor progression remain unknown. Further understanding of how cancer metabolism affects the modification of histones will help guide the development of more effective cancer treatments.

UHRF1 promotes aerobic glycolysis and proliferation via suppression of SIRT4 in pancreatic cancer

UHRF1 (ubiquitin like with plant homeodomain and ring finger domains 1) is an epigenetic modifier that is overexpressed in some cancers, including pancreatic cancer, and mediates silencing of tumor suppressor genes. However, the role of UHRF1 in regulating pancreatic cancer metabolism and metastasis is not clear. In the present study, we demonstrated that silencing UHRF1 significantly inhibited aerobic glycolysis in pancreatic cancer cells. Furthermore, we demonstrated that UHRF1 knockdown decreased hypoxia inducible factor (HIF)1α levels and HIF1α targeted glycolytic genes. The Cancer Genome Atlas dataset analysis supported this observation. The Sirtuin (SIRT) family members regulate aerobic glycolysis in many cancers. We analyzed the correlation between UHRF1 and SIRT3-5 expression and found a significant negative correlation between UHRF1 and SIRT4. Further transcriptional and functional analysis demonstrates that SIRT4 is a downstream target of UHRF1 and negatively regulated aerobic glycolysis, cell proliferation and tumor growth. Our study identified a novel UHRF1/SIRT4 axis in regulation of pancreatic cancer cell proliferation, metabolism, and metastasis.

Updated evaluation of endoscopic submucosal dissection versus surgery for early gastric cancer: A systematic review and meta-analysis

BACKGROUND AND OBJECTIVE

Endoscopic resection (ER) has been a standard treatment modality for early gastric cancer with ignorable risks of lymph node metastasis. As for EGCs within expanded indications, endoscopic submucosal dissection (ESD) has considerable advantages over endoscopic mucosal resection (EMR) regarding higher rate of en bloc resection, complete resection, but lower risk of local recurrence. Previous meta-analyses comparing ESD with surgery for EGC are scarce and not robust to reach definitive conclusions.

METHODS

We searched PubMed, Web of Science, EMBASE, Cochrane Library Databases and Google Scholar through July 2019 to identify studies evaluating ESD vs surgery for EGC. Newcastle-Ottawa Quality Assessment Scale was used to assess the quality of enrolled studies. Patient baseline characteristics, procedure-related and prognosis outcomes, and adverse event data were extracted and pooled for analyses by the Review Manager 5.3 software. Grading of Recommendations Assessment, Development and Evaluation guidelines (GRADE) were used to assess the quality of evidence. Trial Sequential Analysis (TSA) was conducted to weaken random error and enhance the reliability of evidence.

RESULTS

Totally 18 retrospective studies, involving 5993 patients, were included. ESD benefits were 128.38 min shorter operation duration [95%CI: (-204.68, -52.09), P = 0.001], 7.13 days shorter hospital stay [95%CI: (-7.98, -6.28), P < 0.00001], lower risk of procedure-related death [OR = 0.21, 95%CI: (0.07, 0.68), P = 0.009], lower risk of overall complication [OR = 0.47, 95%CI: (0.34, 0.63), P < 0.00001]. ESD was also associated with lower costs and better quality of life. However, ESD had lower rate of en bloc resection [OR = 0.07, 95%CI: (0.03, 0.21), P < 0.00001], histologically complete resection [OR = 0.07, 95%CI: (0.03, 0.14), P < 0.00001], curative resection [OR = 0.06, 95%CI: (0.01, 0.27), P = 0.002], and higher rate of local recurrence [OR = 5.42, 95%CI: (2.91, 10.11), P < 0.00001], metachronous cancer [OR = 10.84, 95%CI: (6.43, 18.26), P < 0.00001], synchronous cancer [OR = 6.59, 95%CI: (1.96, 22.1), P = 0.002]. ESD also led to lower disease-free survival [HR = 4.58, 95%CI: (2.79, 7.52), P < 0.00001] and recurrence-free survival [HR = 1.99, 95%CI: (1.38, 2.87), P = 0.0002]. No significant differences in overall survival (OS) and disease-specific survival (DSS) between ESD and surgery were observed.

CONCLUSIONS

ESD offers a method of less expensive, less trauma, faster recovery and better quality of life compared to surgery for EGC. However, ESD is associated with higher risk of recurrence without compromising OS and DSS. Strict and careful surveillance after ESD is needed. Recurrent EGCs following ESD can usually be detected in early stage and successfully managed by repeated ESD. Accordingly, ESD technique provides an alternative to surgical resection for highly selected EGC patients.

Endoscopic submucosal dissection vs endoscopic mucosal resection for colorectal tumors: A meta-analysis

AIM: To compare the efficacy and safety of endoscopic submucosal dissection (ESD) and endoscopic mucosal resection (EMR) for the treatment of colorectal tumors.

METHODS: Databases, such as PubMed, EMBASE, Cochrane Library and Science Citation Index updated to 2013 were searched to include eligible articles. In the meta-analysis, the main outcome measurements were the en bloc resection rate, the histological resection rate and the local recurrence rate. Meanwhile, we also compared the operation time and the incidence of procedure-related complications.

RESULTS: Six trials were identified and a total of 1642 lesions were included. The en bloc resection rate was higher and the local recurrence rate was lower in the ESD group compared with the EMR group (OR = 7.94; 95%CI: 3.96-15.91; OR = 0.09; 95%CI: 0.04-0.19). There was no significant difference in histological resection rate(OR = 1.65; 95%CI: 0.29-9.30) and procedure-related complication rate between the two groups (OR = 1.59; 95%CI: 0.92-2.73). The meta-analysis also showed that ESD was more time consuming than EMR.

CONCLUSION: Compared with EMR, ESD results in higher en bloc resection rate and lower local recurrence rate for the treatment of colorectal tumors, without increasing the procedure-related complications.

Intraductal papillary neoplasm of the bile duct

Intraductal papillary neoplasm of the bile duct (IPNB) is a variant of bile duct carcinoma that is characterized by intraductal growth and better outcomes compared with common cholangiocarcinoma. IPNBs are mainly found in patients from Far Eastern areas, where hepatolithiasis and clonorchiasis are endemic. According to the immunohistochemical profiles of the mucin core proteins, IPNBs are classified into four types: pancreaticobiliary, intestinal, gastric, and oncocytic. Approximately 40%-80% of IPNBs contain a component of invasive carcinoma or tubular or mucinous adenocarcinoma, suggesting that IPNB is a disease with high potential for malignancy. It is difficult to make an accurate preoperative diagnosis because of IPNB’s low incidence and the lack of specificity in its clinical manifestation. The most common abnormal preoperative imaging findings of IPNB are intraductal masses and the involvement of bile duct dilation. Simultaneous proximal and distal bile duct dilation can be detected in some cases, which has diagnostic significance. Cholangiography and cholangioscopy are needed to confirm the pathology and demonstrate the extent of the lesions. However, pathologic diagnosis by biopsy cannot reflect the actual stage in many cases because different foci may be of different stages and because mixed pathologic findings may exist in the same lesion. Surgical resection is the major treatment. Systematic cholangioscopy with staged biopsies and frozen sections is recommended during resection to ensure that no minor tumors are left and that curative resection is achieved. Staging, histologic subtype, curative resection and lymph node metastasis are factors affecting long-term survival.

Haemoglobin, albumin, lymphocyte and platelet predicts postoperative survival in pancreatic cancer

BACKGROUND

Systemic inflammation and nutrition status play an important role in cancer metastasis. The combined index of hemoglobin, albumin, lymphocyte, and platelet (HALP), consisting of haemoglobin, albumin, lymphocytes, and platelets, is considered as a novel marker to reflect both systemic inflammation and nutrition status. However, no studies have investigated the relationship between HALP and survival of patients with pancreatic cancer following radical resection.

AIM

To evaluate the prognostic value of preoperative HALP in pancreatic cancer patients.

METHODS

The preoperative serum levels of hemoglobin, albumin, lymphocyte counts, and platelet counts were routinely detected in 582 pancreatic adenocarcinoma patients who underwent radical resection. The relationship between postoperative survival and the preoperative level of HALP was investigated.

RESULTS

Low levels of HALP were significantly associated with lymph node metastasis (P = 0.002), poor tumor differentiation (P = 0.032), high TNM stage (P = 0.008), female patients (P = 0.005) and tumor location in the head of the pancreas (P < 0.001). Low levels of HALP were associated with early recurrence [7.3 mo vs 16.3 mo, P < 0.001 for recurrence-free survival (RFS)] and short survival [11.5 mo vs 23.6 mo, P < 0.001 for overall survival (OS)] in patients with resected pancreatic adenocarcinoma. A low level of HALP was an independent risk factor for early recurrence and short survival irrespective of sex and tumor location.

CONCLUSION

Low levels of HALP may be a significant risk factor for RFS and OS in patients with resected pancreatic cancer.

Fecal microbiota transplantation for severe enterocolonic fistulizing Crohn's disease

The concept of fecal microbiota transplantation (FMT) has been used in traditional Chinese medicine at least since the 4(th) century. Evidence from recent human studies strongly supports the link between intestinal bacteria and inflammatory bowel disease. We proposed that standardized FMT might be a promising rescue therapy for refractory inflammatory bowel disease. However, there were no reports of FMT used in patients with severe Crohn's disease (CD). Here, we report the successful treatment of standardized FMT as a rescue therapy for a case of refractory CD complicated with fistula, residual Barium sulfate and formation of intraperitoneal large inflammatory mass. As far as we know, this is the first case of severe CD treated using FMT through mid-gut.

FDG-PET in diagnosis, staging and prognosis of pancreatic carcinoma: a meta-analysis

AIM

To investigate the potential role of positron emission tomography (PET) in the diagnosis, staging and prognosis predicting of pancreatic carcinoma (PC).

METHODS

A systematic review of relevant literatures in PubMed, Embase and Cochrane Library was performed. The sensitivity and specificity of diagnostic and staging studies, and HRs for prognosis predicting studies were pooled. The bivariate model was used for diagnostic studies and the random-effect model for prognostic studies. Heterogeneity between included studies was tested using χ(2) test, and subgroup analysis was performed to explain the heterogeneities. All of the calculations were performed using Stata version 11.0.

RESULTS

A total of 39 studies were included. The pooled sensitivity of PET in diagnosing PC (30 studies, 1582 patients), evaluating N stating (4 studies, 101 patients) and liver metastasis (7 studies, 316 patients) were 0.91 (95%CI: 0.88-0.93), 0.64 (95%CI: 0.50-0.76), and 0.67 (95%CI: 0.52-0.79), respectively; and the corresponding specificity was 0.81 (95%CI: 0.75-0.85), 0.81 (95%CI: 0.25-0.85), and 0.96 (95%CI: 0.89-0.98), respectively. In prognosis analysis (6 studies, 198 patients), significant difference of overall survival was observed between high and low standardized uptake value groups (HR = 2.39, 95%CI: 1.57-3.63). Subgroup analysis showed that PET/CT was more sensitive than PET alone in evaluating liver metastasis of PC, 0.82 (95%CI: 0.48-0.98) and 0.67 (95%CI: 0.52-0.79), respectively.

CONCLUSION

PET can be used as a valuable diagnostic and predictive tool for PC, but its effect in the staging of PC remains indeterminate.

Doppler-based renal resistive index for prediction of renal dysfunction reversibility: A systematic review and meta-analysis

BACKGROUND AND OBJECTIVES

Doppler-based renal resistive index (RI) might help in distinguishing transient from persistent acute kidney injury (AKI). The main objective of these systematic review and meta-analysis was to investigate the diagnostic performance of RI in predicting short-term reversibility of AKI.

STUDY DESIGN

A systematic review of the literature was performed. Relevant studies were identified in Pubmed and Cochrane databases covering the years 1985 to 2013 and reviewed independently by 3 authors. Renal transplant recipients were excluded from this analysis. The summary estimates were computed using a random-effects model based on the DerSimonian and Lair meta-analytic method.

RESULTS

Among the 154 unique articles identified, 9 studies were included. Of the 176 patients in these studies with elevated RI or pulsatility index, 146 (83%) had a persistent AKI vs 44 (16%) of the 273 patients with normal values. Elevated RI or pulsatility index was associated with an increased risk of persistent AKI (odds ratio, 29.85; 95% confidence interval [CI], 8.73-102.16; P < .00001) with significant heterogeneity (I(2) = 75.0%, P < .0001). The pooled sensitivity and specificity were 0.83 (95% CI, 0.77-0.88) and 0.84 (95% CI, 0.79-0.88). The summary positive and negative likelihood ratios were 4.9 (95% CI, 2.44-9.87) and 0.21 (95% CI, 0.11-0.41).

CONCLUSION

These results suggest that an elevated RI may be a predictor of persistent AKI in critically ill patients. Further studies are warranted, however, to clarify the exact test performance given the marked heterogeneity among the included studies.

Gastrointestinal motility disorders in inflammatory bowel diseases

The relationship between motility and inflammatory gastrointestinal disorders is at the same time complex and intriguing since these conditions might share some genetic, environmental, immunological and microbial predisposing factors. In addition, significant symptom overlapping may occur, muddling the waters within the clinical context. Although on one hand this represents a challenge for the clinician for a potential under- or over-treatment and diagnostic delay, on the other hand it possibly represents an opportunity for the researcher to better disclose the intimate relationship between chronic (often low-grade) inflammation, motor disorders and deranged sensory function. The best example is probably represented by Crohn's disease and ulcerative colitis. In fact, a number of gastrointestinal motor disorders have been described in association with these diseases, disorders which span from the esophagus to the anorectum, and which will be extensively covered in this review. It is conceivable that at least part of this derangement is strictly related to inflammatory cytokine trafficking and neuromuscular changes; however, given the high prevalence of functional gastrointestinal disorders in the general population, this overlap might also be serendipitous. However, it is worth noting that literature data on this topic are relatively scarce, sometimes quite outdated, and mostly focused on the interplay between irritable bowel syndrome and inflammatory bowel disease. Nevertheless, both researchers and clinicians must be aware that symptoms related to gastrointestinal motility disorders may be highly prevalent in both active and inactive inflammatory bowel disease, correlate with greater psychological comorbidity and poorer quality of life, and may negatively influence the therapeutic approaches.

Chinese expert consensus on cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal malignancies

Locoregional spread of abdominopelvic malignant tumors frequently results in peritoneal carcinomatosis (PC). The prognosis of PC patients treated by conventional systemic chemotherapy is poor, with a median survival of < 6 mo. However, over the past three decades, an integrated treatment strategy of cytoreductive surgery (CRS) + hyperthermic intraperitoneal chemotherapy (HIPEC) has been developed by the pioneering oncologists, with proved efficacy and safety in selected patients. Supported by several lines of clinical evidence from phases I, II and III clinical trials, CRS + HIPEC has been regarded as the standard treatment for selected patients with PC in many established cancer centers worldwide. In China, an expert consensus on CRS + HIPEC has been reached by the leading surgical and medical oncologists, under the framework of the China Anti-Cancer Association. This expert consensus has summarized the progress in PC clinical studies and systematically evaluated the CRS + HIPEC procedures in China as well as across the world, so as to lay the foundation for formulating PC treatment guidelines specific to the national conditions of China.

Ten-year survival of hepatocellular carcinoma patients undergoing radiofrequency ablation as a first-line treatment

AIM: To investigate the long-term survival and prognostic factors in hepatocellular carcinoma (HCC) patients undergoing radiofrequency ablation (RFA) as a first-line treatment.

METHODS: From 2000 to 2013, 316 consecutive patients with 404 HCC (1.0-5.0 cm; mean: 3.2 ± 1.1 cm) underwent ultrasonography-guided percutaneous RFA as a first-line treatment. There were 250 males and 66 females with an average age of 60.1 ± 10.8 years (24-87 years). Patients were followed for 1 year to > 10 years after RFA (234, 181, 136, and 71 for 3, 5, 7, and 10 years, respectively). Overall local response rates and long-term survival rates were assessed. Survival results were generated using Kaplan-Meier estimates, and multivariate analysis was performed using the Cox regression model.

RESULTS: In total, 548 RFA sessions were performed and major complications occurred in 10 sessions (1.8%). Local tumor progression and/or new tumor development were observed in 43.3% (132/305) of the patients during the follow-up period. Overall 5- and 10-year survival rates were 49.7% and 28.4%, respectively. Based on multivariate analysis, three factors were identified as independent prognostic factors for overall survival: Child-Pugh classification (HR = 4.054, P < 0.001), portal vein hypertension (HR = 2.743, P = 0.002), and tumor number (HR = 2.693, P = 0.003). The local progression-free 5- and 10-year survival rates were 42.7% and 19.5%. In addition to the Child-Pugh classification and the number of tumors, the number of RFA sessions (HR = 1.550, P = 0.002) was associated with local progression-free survival.

CONCLUSION: RFA can achieve acceptable outcomes for HCC patients as a first-line treatment, especially for patients with Child-Pugh class A, patients with a single tumor and patients without portal vein hypertension.

Curcumin protects against acetaminophen-induced apoptosis in hepatic injury

AIM: To explore the effects of curcumin (CMN) on hepatic injury induced by acetaminophen (APAP) in vivo.

METHODS: Male mice were randomly divided into three groups: group I (control) mice received the equivalent volumes of phosphate-buffered saline (PBS) intraperitoneally (ip); Group II [APAP + carboxymethylcellulose (CMC)] mice received 1% CMC (vehicle) 2 h before APAP injection; Group III (APAP + CMN) mice received curcumin (10 or 20 mg/kg, ip) 2 h before before or after APAP challenge. In Groups II and III, APAP was dissolved in pyrogen-free PBS and injected at a single dose of 300 mg/kg. CMN was dissolved in 1% CMC. Mice were sacrificed 16 h after the APAP injection to determine alanine aminotransferase (ALT) levels in serum and malondialdehyde (MDA) accumulation, superoxide dismutase (SOD) activity and hepatocyte apoptosis in liver tissues.

RESULTS: Both pre- and post-treatment with curcumin resulted in a significant decrease in serum ALT compared with APAP treatment group (10 mg/kg: 801.46 ± 661.34 U/L; 20 mg/kg: 99.68 ± 86.48 U/L vs 5406.80 ± 1785.75 U/L, P < 0.001, respectively). The incidence of liver necrosis was significantly lowered in CMN treated animals. MDA contents were significantly reduced in 20 mg/kg CMN pretreatment group, but increased in APAP treated group (10.96 ± 0.87 nmol/mg protein vs 16.03 ± 2.58 nmol/mg protein, P < 0.05). The decrease of SOD activity in APAP treatment group and the increase of SOD in 20 mg/kg CMN pretreatment group were also detected (24.54 ± 4.95 U/mg protein vs 50.21 ± 1.93 U/mg protein, P < 0.05). Furthermore, CMN treatment efficiently protected against APAP-induced apoptosis via increasing Bcl-2/Bax ratio.

CONCLUSION: CMN has significant therapeutic potential in both APAP-induced hepatotoxicity and other types of liver diseases.

Multifaceted p21 in carcinogenesis, stemness of tumor and tumor therapy

Cancer cells possess metabolic properties that are different from those of benign cells. p21, encoded by CDKN1A gene, also named p21^Cip1/WAF1, was first identified as a cyclin-dependent kinase regulator that suppresses cell cycle G1/S phase and retinoblastoma protein phosphorylation. CDKN1A (p21) acts as the downstream target gene of TP53 (p53), and its expression is induced by wild-type p53 and it is not associated with mutant p53. p21 has been characterized as a vital regulator that involves multiple cell functions, including G1/S cell cycle progression, cell growth, DNA damage, and cell stemness. In 1994, p21 was found as a tumor suppressor in brain, lung and colon cancer by targeting p53 and was associated with tumorigenesis and metastasis. Notably, p21 plays a significant role in tumor development through p53-dependent and p53-independent pathways. In addition, expression of p21 is closely related to the resting state or terminal differentiation of cells. p21 is also associated with cancer stem cells and acts as a biomarker for such cells. In cancer therapy, given the importance of p21 in regulating the G1/S and G2 check points, it is not surprising that p21 is implicated in response to many cancer treatments and p21 promotes the effect of oncolytic virotherapy.

Hepatitis B or C viral infection and risk of pancreatic cancer: A meta-analysis of observational studies

AIM: To investigate if there is an association between hepatitis B virus (HBV) or hepatitis C virus (HCV) infection and the risk of pancreatic cancer.

METHODS: All relevant studies published before 11 October, 2012 were identified by a systematic search of MEDLINE, EMBASE, BIOSIS Previews and the Cochrane Library databases and with cross-referencing. The observational studies that reported RR or OR estimates with 95%CIs for the association between HBV or HCV and pancreatic cancer were included. A random-effects model was used to summarize meta-analytic estimates. The Newcastle-Ottawa quality assessment scale was applied to assess the quality of the methodology in the included studies.

RESULTS: A total of 8 eligible studies were selected for meta-analysis. Overall, chronic hepatitis B and inactive hepatitis B surface antigen (HBsAg) carrier state (HBsAg positive) had a significantly increased risk of pancreatic cancer with OR of 1.20 (95%CI: 1.01-1.39), especially in the Chinese population (OR = 1.30, 95%CI: 1.05-1.56). Past exposure to HBV (possible occult HBV infection) had an increased OR of pancreatic cancer risk (OR = 1.24, 95%CI: 1.05-1.42), especially among those patients without natural immunity [anti hepatitis B core (HBc) positive/hepatitis B surface antibody (anti HBs) negative], with OR of 1.67 (95%CI: 1.13-2.22). However, past exposure to HBV with natural immunity (anti-HBc positive/anti-HBs positive) had no association with pancreatic cancer development, with OR 0.98 (95%CI: 0.80-1.16), nor did the HBV active replication (hepatitis B e antigen positive status), with OR 0.98 (95%CI: 0.27-1.68). The risk of pancreatic cancer among anti-HBs positive patients was significantly lower than among anti-HBs negative patients (OR = 0.54, 95%CI: 0.46-0.62). Past exposure to HCV also resulted in an increased risk of pancreatic cancer (OR = 1.26, 95%CI: 1.03-1.50). Significant between-study heterogeneity was observed. Evidence of publication bias for HBV/HCV infection-pancreatic cancer association was not found.

CONCLUSION: Chronic HBV and HCV infection increases pancreatic cancer risk. Our findings underscore the need for more studies to confirm this potential relationship.

Prediction of risk factors for lymph node metastasis in early gastric cancer

AIM: To explore risk factors for lymph node metastases in early gastric cancer (EGC) and to confirm the appropriate range of lymph node dissection.

METHODS: A total of 202 patients with EGC who underwent curative gastrectomy with lymphadenectomy in the Department of Surgery, Xinhua Hospital and Ruijin Hospital of Shanghai Jiaotong University Medical School between November 2003 and July 2009, were retrospectively reviewed. Both the surgical procedure and the extent of lymph node dissection were based on the recommendations of the Japanese gastric cancer treatment guidelines. The macroscopic type was classified as elevated (type I or IIa), flat (IIb), or depressed (IIc or III). Histopathologically, papillary and tubular adenocarcinomas were grouped together as differentiated adenocarcinomas, and poorly differentiated and signet-ring cell adenocarcinomas were regarded as undifferentiated adenocarcinomas. Univariate and multivariate analyses of lymph node metastases and patient and tumor characteristics were undertaken.

RESULTS: The lymph node metastases rate in patients with EGC was 14.4%. Among these, the rate for mucosal cancer was 5.4%, and 8.9% for submucosal cancer. Univariate analysis showed an obvious correlation between lymph node metastases and tumor location, depth of invasion, morphological classification and venous invasion (χ² = 122.901, P = 0.001; χ² = 7.14, P = 0.008; χ² = 79.523, P = 0.001; χ² = 8.687, P = 0.003, respectively). In patients with submucosal cancers, the lymph node metastases rate in patients with venous invasion (60%, 3/5) was higher than in those without invasion (20%, 15/75) (χ² = 4.301, P = 0.038). Multivariate logistic regression analysis revealed that the depth of invasion was the only independent risk factor for lymph node metastases in EGC [P = 0.018, Exp (B) = 2.744]. Among the patients with lymph node metastases, 29 cases (14.4%) were at N1, seven cases were at N2 (3.5%), and two cases were at N3 (1.0%). Univariate analysis of variance revealed a close relationship between the depth of invasion and lymph node metastases at pN₁ (P = 0.008).

CONCLUSION: The depth of invasion was the only independent risk factor for lymph node metastases. Risk factors for metastases should be considered when choosing surgery for EGC.

Regional but fatal: Intraperitoneal metastasis in gastric cancer

Peritoneal carcinomatosis appears to be the most common pattern of metastasis or recurrence and is associated with poor prognosis in gastric cancer patients. Many efforts have been made to improve the survival in patients with peritoneal metastasis. Hyperthermic intraperitoneal chemotherapy remains a widely accepted strategy in the treatment of peritoneal dissemination. Several phase II-III studies confirmed that the combined cytoreducitve surgery and hyperthermic intraperitoneal chemotherapy resulted in longer survival in patients with peritoneal carcinomatosis. In addition, proper selection and effective regional treatment in patients with high risk of peritoneal recurrence after resection will further improve prognosis in local advanced gastric cancer patients.

In vivo hepatic differentiation potential of human umbilical cord-derived mesenchymal stem cells: Therapeutic effect on liver fibrosis/cirrhosis

AIM

To investigate the hepatic differentiation potential of human umbilical cord-derived mesenchymal stem cells (hUC-MSCs) and to evaluate their therapeutic effect on liver fibrosis/cirrhosis.

METHODS

A CCl4-induced liver fibrotic/cirrhotic rat model was used to assess the effect of hUC-MSCs. Histopathology was assessed by hematoxylin and eosin (H&E), Masson trichrome and Sirius red staining. The liver biochemical profile was measured using a Beckman Coulter analyzer. Expression analysis was performed using immunofluorescent staining, immunohistochemistry, Western blot, and real-time PCR.

RESULTS

We demonstrated that the infused hUC-MSCs could differentiate into hepatocytes in vivo. Functionally, the transplantation of hUC-MSCs to CCl4-treated rats improved liver transaminases and synthetic function, reduced liver histopathology and reversed hepatobiliary fibrosis. The reversal of hepatobiliary fibrosis was likely due to the reduced activation state of hepatic stellate cells, decreased collagen deposition, and enhanced extracellular matrix remodeling via the up-regulation of MMP-13 and down-regulation of TIMP-1.

CONCLUSION

Transplanted hUC-MSCs could differentiate into functional hepatocytes that improved both the biochemical and histopathologic changes in a CCl4-induced rat liver fibrosis model. hUC-MSCs may offer therapeutic opportunities for treating hepatobiliary diseases, including cirrhosis.

How hepatitis C virus invades hepatocytes: The mystery of viral entry

Hepatitis C virus (HCV) infection is a global health problem, with an estimated 170 million people being chronically infected. HCV cell entry is a complex multi-step process, involving several cellular factors that trigger virus uptake into the hepatocytes. The high- density lipoprotein receptor scavenger receptor class B type I, tetraspanin CD81, tight junction protein claudin-1, and occludin are the main receptors that mediate the initial step of HCV infection. In addition, the virus uses cell receptor tyrosine kinases as entry regulators, such as epidermal growth factor receptor and ephrin receptor A2. This review summarizes the current understanding about how cell surface molecules are involved in HCV attachment, internalization, and membrane fusion, and how host cell kinases regulate virus entry. The advances of the potential antiviral agents targeting this process are introduced.

Prevalence of minimal hepatic encephalopathy and quality of life evaluations in hospitalized cirrhotic patients in China

AIM

To investigate the prevalence of minimal hepatic encephalopathy (MHE) and to assess corresponding health-related quality of life (HRQoL) in hospitalized cirrhotic patients in China.

METHODS

This multi-center cross-sectional study included 16 teaching hospitals, which were members of "Hepatobiliary Cooperation Group, Society of Gastroenterology, Chinese Medical Association", from different areas of China carried out between June and October in 2011. All the eligible hospitalized cirrhotic patients (n = 538) were required to complete triplicate number connection tests combined with one digit symbol test for diagnosing MHE. Patients' clinical examination data were complemented by a modified questionnaire assessing HRQoL. Written informed consent was obtained from each patient.

RESULTS

Male was predominant (68.6%) in 519 patients who met the criteria of the study, with a mean age of 49.17 ± 11.02 years. The most common cause of liver cirrhosis was chronic hepatitis B (55.9%). The prevalence of MHE was 39.9% and varied by Child-Pugh-Classification score (CPC-A: 24.8%, CPC-B: 39.4% and CPC-C: 56.1%, P < 0.01). MHE (P < 0.01) and higher CPC scores (P < 0.01) were associated with a high HRQoL scores (reflecting poorer quality of life). The prevalence of MHE was proportionate to CPC (P = 0.01) and high quality of life scores (P = 0.01).

CONCLUSION

Hospitalized cirrhotic patients have a high prevalence of MHE that is proportionate to the degree of liver function and HRQoL impairment.

The efficacy of randomised controlled trials of cognitive behaviour therapy for perfectionism: a systematic review and meta-analysis

Perfectionism is a transdiagnostic process across anxiety, depression, and eating disorders. The aim of this systematic review was to examine the efficacy of self-help and face to face CBT for perfectionism in reducing perfectionism and anxiety, depression, and eating disorders. A total of 15 randomised controlled trials of CBT for perfectionism were identified (N = 912 participants; mean pooled age = 23 years) which met inclusion criteria. There were medium or large effect sizes found on perfectionism measures; personal standards (g = 0.57, 95% CI = 0.43-0.72), concern over mistakes (g = 0.89, 95% CI = 0.71-1.08) and clinical perfectionism (g = 0.87, 95% CI = 0.70-1.04). There were medium effects for symptoms of eating disorders (g = 0.61, 95% CI = 0.36-0.87) and depression (g = 0.60, 95% CI = 0.28-0.91), and a small-medium effect on anxiety (g = 0.42, 95% CI = 0.21-0.62). There was no publication bias found. Limitations included the small number of trials included and lack of active treatment comparisons. Results suggested that CBT for perfectionism is efficacious in reducing perfectionism and symptoms of depression, anxiety and eating disorders. Future research should examine comparisons of CBT for perfectionism with other psychological treatments.